Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 65
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Loss of the epithelial marker CDX1 predicts poor prognosis in early-stage CRC patients

  • Solé Font, Laura|||0000-0002-3195-0565
  • Lobo-Jarne, Teresa|||0000-0002-1632-438X
  • Cabré-Romans, Júlia-Jié
  • González, Antón
  • Fernández, Lierni
  • Marruecos, Laura|||0000-0002-4206-709X
  • Guix, Marta|||0000-0002-2143-0697
  • Cuatrecasas, Miriam|||0000-0003-3063-0110
  • López, Sandra
  • Bellosillo Paricio, Beatriz|||0000-0002-5335-2726
  • Torres, Ferran|||0000-0002-7355-7913
  • Iglesias, Mar|||0000-0002-2274-4671
  • Bigas Salvans, Anna|||0000-0003-4801-6899
  • Espinosa, Lluis|||0000-0002-2897-4099
Background: We have previously shown that non-curative chemotherapy imposes fetal conversion and high metastatic capacity to cancer cells. From the set of genes differentially expressed in Chemotherapy Resistant Cells, we obtained a characteristic fetal intestinal cell signature that is present in a group of untreated tumors and is sufficient to predict patient prognosis. A feature of this fetal signature is the loss of CDX1. Methods: We have analyzed transcriptomic data in public datasets and performed immunohistochemistry analysis of paraffin embedded tumor samples from two cohorts of colorectal cancer patients. Results: We demonstrated that low levels of CDX1 are sufficient to identify patients with poorest outcome at the early tumor stages II and III. Presence tumor areas that are negative for CDX1 staining in stage I cancers is associated with tumor relapse. Conclusions: Our results reveal the actual possibility of incorporating CDX1 immunostaining as a valuable biomarker for CRC patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Electrochemical reduction mechanism of 4-nitrobenzyl bromide in ionogel membranes

  • Naeem, Tehreema|||0009-0007-6034-0348
  • Mena Fernández, Silvia|||0000-0002-2800-2388
  • Hernando, Jordi|||0000-0002-1126-4138
  • Guirado, Gonzalo|||0000-0003-2128-7007
Ionic liquid-based electrolytes (ILs) have gained tremendous attention as sustainable, green electrolytes for electrochemical processes due to their negligible vapour pressure and high boiling points. A rising trend is to fabricate solid electrolytes based on ionic liquids to address the risk of leakage associated to liquid electrolytes. These solid electrolytes, which are commonly known as ionogel membranes (IGs), contain the intrinsic properties of ILs, while having excellent mechanical strength. These characteristics make them ideal for investigating reaction mechanisms and facilitating electrosynthesis processes. By providing a stable and conductive environment, ionogels enable precise control and monitoring of electrochemical reactions in solid electrolytes, leading to more accurate and reproducible results. Their application not only enhances our understanding of fundamental electrochemical processes but also paves the way for innovative advancements in electrosynthesis, contributing significantly to the development of new materials and technologies. In this body of research, the reduction mechanism of p-nitrobenzyl bromide (p-NBBr) is studied and disclosed in IG membranes for a first time. We successfully performed a controlled potential electrolysis of p-NBBr in IG membranes, as well as studying two different electrochemical setups to obtain the most optimal configuration. We also demonstrate that the addition of electrolyte additives, such as lithium bis(trifluorometahnesulfonyl)imide (Li TFSI), in the IG composition raises the ionic conductivity of the resulting membrane from 0.15 up to 0.2 mS/cm.
Repisalud
Publicación Artículo científico (JournalArticle)

Reproductive risk factors in breast cancer and genetic hormonal pathways: a gene-environment interaction in the MCC-Spain project

  • Dierssen-Sotos, Trinidad
  • Palazuelos-Calderón, Camilo
  • Jimenez-Moleon, Jose J.
  • Aragones, Nuria
  • Altzibar, Jone M
  • Castaño-Vinyals, Gemma
  • Martín-Sánchez, Vicente
  • Gómez-Acebo, Inés
  • Guevara, Marcela
  • Tardón, Adonina
  • Perez-Gomez, Beatriz
  • Amiano, Pilar
  • Moreno, Victor
  • Molina, Antonio J
  • Alonso-Molero, Jéssica
  • Moreno-Iribas, Conchi
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Llorca, Javier
BACKGROUND: Reproductive factors are well known risk factors for breast cancer; however, little is known about how genetic variants in hormonal pathways interact with that relationship. METHODS: One thousand one hundred thirty nine cases of breast cancer in women and 1322 frequency-matched controls were compared. Genetic variants in hormonal pathways (identified in the Kyoto Encyclopedia of Genes and Genomes) were screened according to their relationship with breast cancer using the Cochran-Armitage statistic. Information on reproductive factors was obtained using a face-to-face questionnaire. The interaction among the selected genetic variants and reproductive factors was tested with logistic regression. RESULTS: Concerning C allele in rs2229712, compared to nulliparity in non-carriers the ORs for 1-2 and > 2 deliveries were 0.48 (0.28-0.81) and 0.34 (0.19-0.59), and in C carriers they were 0.92 (0.42-1.98) and 0.71 (0.31-1.61). Similar results were found in women carrying the C allele in rs1269851. Carriers of Allele T in rs35652107 and allele C in rs6018027 had the delivery number effect more pronounced. CONCLUSIONS: The number of deliveries had a dose-response protective effect on breast cancer; women carrying C allele in rs2229712 did not benefit from this protective effect.
Repisalud
Publicación Artículo científico (JournalArticle)

Possible role of chondroitin sulphate and glucosamine for primary prevention of colorectal cancer. Results from the MCC-Spain study

  • Ibáñez-Sanz, Gemma
  • Díez-Villanueva, Anna
  • Vilorio-Marqués, Laura
  • Gracia, Esther
  • Aragones, Nuria
  • Olmedo-Requena, Rocío
  • Llorca, Javier
  • Vidán, Juana
  • Amiano, Pilar
  • Nos, Pilar
  • Fernández-Tardón, Guillermo
  • Rada, Ricardo
  • Chirlaque, María-Dolores
  • Guinó, Elisabet
  • Dávila-Batista, Verónica
  • Castaño-Vinyals, Gemma
  • Perez-Gomez, Beatriz
  • Mirón-Pozo, Benito
  • Dierssen-Sotos, Trinidad
  • Etxeberria, Jaione
  • Molinuevo, Amaia
  • Álvarez-Cuenllas, Begoña
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Moreno, Victor
A safe and effective colorectal cancer (CRC) chemoprevention agent remains to be discovered. We aim to evaluate the association between the use of glucosamine and/or chondroitin sulphate and risk of colorectal cancer (CRC) in the MCC-Spain study, a case-control study performed in Spain that included 2140 cases of CRC and 3950 population controls. Subjects were interviewed on sociodemographic factors, lifestyle, family and medical history and regular drug use. Adjusted odds ratios and their 95% confidence intervals were estimated. The reported frequency of chondroitin and/or glucosamine use was 2.03% in controls and 0.89% in cases. Users had a reduced risk of CRC (OR: 0.47; 95% CI: 0.28-0.79), but it was no longer significant when adjusted for NSAID (nonsteroidal anti-inflammatory drugs) use (OR: 0.82; 95% CI: 0.47-1.40). A meta-analysis with previous studies suggested a protective effect, overall and stratified by NSAID use (OR: 0.77; 95% CI: 0.62-0.97). We have not found strong evidence of an independent preventive effect of CG on CRC in our population because the observed effects of our study could be attributed to NSAIDs concurrent use. These results merit further research due to the safety profile of these drugs.
Repisalud
Publicación Artículo científico (JournalArticle)

Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain

  • Fernandez de Larrea-Baz, Nerea
  • Michel, Angelika
  • Romero, Beatriz
  • Perez-Gomez, Beatriz
  • Moreno, Victor
  • Martín, Vicente
  • Dierssen-Sotos, Trinidad
  • Jimenez-Moleon, Jose J.
  • Castilla Catalán, Jesús
  • Tardón, Adonina
  • Ruiz, Irune
  • Peiró, Rosana
  • Tejada, Antonio
  • Chirlaque, María-Dolores
  • Butt, Julia A
  • Olmedo-Requena, Rocío
  • Gómez-Acebo, Inés
  • Linares, Pedro
  • Boldo, Elena
  • Castells, Antoni
  • Pawlita, Michael
  • Castaño-Vinyals, Gemma
  • Kogevinas, Manolis
  • de Sanjose, Silvia
  • Pollan-Santamaria, Marina
  • Del Campo, Rosa
  • Waterboer, Tim
  • Aragones, Nuria
Background: Several studies have suggested that Helicobacter pylori (H. pylori) infection is a risk factor for colorectal cancer (CRC), while others have not confirmed this hypothesis. This work aimed to assess the relation of CRC with H. pylori seropositivity and with seropositivity to 16 H. pylori proteins, in the MultiCase-Control study, MCC-Spain. Methods: MCC-Spain is a multicase-control study carried out in Spain from 2008 to 2013. In total, 2,140 histologically-confirmed incident CRC cases and 4,098 population-based controls were recruited. Controls were frequency-matched by sex, age, and province. Epidemiological data were collected through a questionnaire fulfilled by face-to-face interviews and a self-administered food-frequency questionnaire. Seroreactivities against 16 H. pylori proteins were determined in 1,488 cases and 2,495 controls using H. pylori multiplex serology. H. pylori seropositivity was defined as positivity to ≥4 proteins. Multivariable logistic regression mixed models were used to estimate odds ratios (OR) and 95% confidence intervals (CI). Results:H. pylori seropositivity was not associated with increased CRC risk (OR = 0.91; 95% CI: 0.71-1.16). Among H. pylori seropositive subjects, seropositivity to Cagδ showed a lower CRC risk, and risk decreased with increasing number of proteins seropositive. Seropositivity to the most recognized virulence factors, CagA and VacA, was not associated with a higher CRC risk. No statistically significant heterogeneity was identified among tumor sites, although inverse relations were stronger for left colon cancer. An interaction with age and sex was found: H. pylori seropositivity was associated with a lower CRC risk in men younger than 65 and with a higher risk in older women. Conclusions: Our results suggest that neither H. pylori seropositivity, nor seropositivity to the virulence factor CagA are associated with a higher CRC risk. A possible effect modification by age and sex was identified.
Repisalud
Publicación Artículo científico (JournalArticle)

Association between Polyphenol Intake and Gastric Cancer Risk by Anatomic and Histologic Subtypes: MCC-Spain

  • Rubín-García, María
  • Vitelli-Storelli, Facundo
  • Molina, Antonio José
  • Zamora-Ros, Raúl
  • Aragones, Nuria
  • Adarnaz, Eva
  • Castaño-Vinyals, Gemma
  • Obón-Santacana, Mireia
  • Gómez-Acebo, Inés
  • Molina-Barceló, Ana
  • Fernández-Tardón, Guillermo
  • Jimenez-Moleon, Jose J.
  • Alguacil, Juan
  • Chirlaque, María-Dolores
  • Toledo, Estefanía
  • Perez-Gomez, Beatriz
  • Pollan-Santamaria, Marina
  • Kogevinas, Manolis
  • Martín, Vicente
Several anticancer properties have been largely attributed to phenolics in in vivo and in vitro studies, but epidemiologic evidence is still scarce. Furthermore, some classes have not been studied in relation to gastric cancer (GC). The aim of this study was to assess the relationship between the intake of phenolic acids, stilbenes, and other phenolics and the risk of developing GC and its anatomical and histological subtypes. We used data from a multi-case-control study (MCC-Spain) obtained from different regions of Spain. We included 2700 controls and 329 GC cases. Odds ratios (ORs) were calculated using mixed effects logistic regression considering quartiles of phenolic intake. Our results showed an inverse association between stilbene and lignan intake and GC risk (ORQ4 vs. Q1 = 0.47; 95% CI: 0.32-0.69 and ORQ4 vs. Q1 = 0.53; 95% CI: 0.36-0.77, respectively). We found no overall association between total phenolic acid and other polyphenol class intake and GC risk. However, hydroxybenzaldehydes (ORQ4 vs. Q1 = 0.41; 95% CI: 0.28-0.61), hydroxycoumarins (ORQ4 vs. Q1 = 0.49; 95% CI: 0.34-0.71), and tyrosols (ORQ4 vs. Q1 = 0.56; 95% CI: 0.39-0.80) were inversely associated with GC risk. No differences were found in the analysis by anatomical or histological subtypes. In conclusion, a diet high in stilbenes, lignans, hydroxybenzaldehydes, hydroxycoumarins, and tyrosols was associated with a lower GC risk. Further prospective studies are needed to confirm our results.
Repisalud
Publicación Artículo científico (JournalArticle)

Risk of breast cancer and residential proximity to industrial installations: New findings from a multicase-control study (MCC-Spain)

  • García-Pérez, Javier
  • Lope Carvajal, Virginia
  • Perez-Gomez, Beatriz
  • Molina, Antonio José
  • Tardón, Adonina
  • Díaz Santos, María Angustias
  • Ardanaz, Eva
  • O'Callaghan-Gordo, Cristina
  • Altzibar, Jone M
  • Gómez-Acebo, Inés
  • Moreno, Victor
  • Peiró, Rosana
  • Marcos-Gragera, Rafael
  • Kogevinas, Manolis
  • Aragones, Nuria
  • Lopez-Abente, Gonzalo
  • Pollan-Santamaria, Marina
Breast cancer is the most frequent tumor in women worldwide, although well-established risk factors account for 53%-55% of cases. Therefore, other risk factors, including environmental exposures, may explain the remaining variation. Our objective was to assess the relationship between risk of breast cancer and residential proximity to industries, according to categories of industrial groups and specific pollutants released, in the context of a population-based multicase-control study of incident cancer carried out in Spain (MCC-Spain). Using the current residence of cases and controls, this study was restricted to small administrative divisions, including both breast cancer cases (452) and controls (1511) in the 10 geographical areas recruiting breast cancer cases. Distances were calculated from the respective woman's residences to the 116 industries located in the study area. We used logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (95%CIs) for categories of distance (between 1 km and 3 km) to industrial plants, adjusting for matching variables and other confounders. Excess risk (OR; 95%CI) of breast cancer was found near industries overall (1.30; 1.00-1.69 at 3 km), particularly organic chemical industry (2.12; 1.20-3.76 at 2.5 km), food/beverage sector (1.87; 1.26-2.78 at 3 km), ceramic (4.71; 1.62-13.66 at 1.5 km), surface treatment with organic solvents (2.00; 1.23-3.24 at 3 km), and surface treatment of plastic and metals (1.51; 1.06-2.14 at 3 km). By pollutants, the excess risk (OR; 95%CI) was detected near industries releasing pesticides (2.09; 1.14-3.82 at 2 km), and dichloromethane (2.09; 1.28-3.40 at 3 km). Our results suggest a possible increased risk of breast cancer in women living near specific industrial plants and support the need for more detailed exposure assessment of certain agents released by these plants.
Repisalud
Publicación Artículo científico (JournalArticle)

Pigmentation phototype and prostate and breast cancer in a select Spanish population-A Mendelian randomization analysis in the MCC-Spain study

  • Gómez-Acebo, Inés
  • Dierssen-Sotos, Trinidad
  • Palazuelos, Camilo
  • Fernandez-Navarro, Pablo L
  • Castaño-Vinyals, Gemma
  • Alonso-Molero, Jéssica
  • Urtiaga, Carmen
  • Fernández-Villa, Tania
  • Ardanaz, Eva
  • Rivas-Del-Fresno, Manuel
  • Molina-Barceló, Ana
  • Jimenez-Moleon, Jose J.
  • García-Martínez, Lidia
  • Amiano, Pilar
  • Rodríguez-Cundín, Paz
  • Moreno, Victor
  • Perez-Gomez, Beatriz
  • Aragones, Nuria
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Llorca, Javier
INTRODUCTION: Phototype has been associated with an increased risk of prostate cancer, and it is yet unknown if it is related to other hormone-dependent cancers, such as breast cancer or whether this association could be considered causal. METHODS: We examined the association between the phototype and breast and prostate cancers using a Mendelian randomization analysis. We studied 1,738 incident cases of breast cancer and another 817 cases of prostate cancer. To perform a Mendelian randomization analysis on the phototype-cancer relationship, a genetic pigmentation score was required that met the following criteria: (1) the genetic pigmentation score was associated with phototype in controls; (2) the genetic pigmentation score was not associated with confounders in the relationship between phototype and cancer, and (3) the genetic pigmentation score was associated with cancer only through its association with phototype. Once this genetic score is available, the association between genetic pigmentation score and cancer can be identified as the association between phototype and cancer. RESULTS: The association between the genetic pigmentation score and phototype in controls showed that a higher genetic pigmentation score was associated with fair skin, blond hair, blue eyes and the presence of freckles. Applying the Mendelian randomization analysis, we verified that there was no association between the genetic pigmentation score and cancers of the breast and prostate. CONCLUSIONS: Phototype is not associated with breast or prostate cancer.
Repisalud
Publicación Artículo científico (JournalArticle)

Risk Model for Prostate Cancer Using Environmental and Genetic Factors in the Spanish Multi-Case-Control (MCC) Study

  • Gómez-Acebo, Inés
  • Dierssen-Sotos, Trinidad
  • Fernandez-Navarro, Pablo L
  • Palazuelos, Camilo
  • Moreno, Victor
  • Aragones, Nuria
  • Castaño-Vinyals, Gemma
  • Jimenez-Moleon, Jose J.
  • Ruiz-Cerdá, Jose Luis
  • Perez-Gomez, Beatriz
  • Ruiz-Dominguez, José Manuel
  • Molero, Jessica Alonso
  • Pollan-Santamaria, Marina
  • Kogevinas, Manolis
  • Llorca, Javier
Prostate cancer (PCa) is the second most common cancer among men worldwide. Its etiology remains largely unknown compared to other common cancers. We have developed a risk stratification model combining environmental factors with family history and genetic susceptibility. 818 PCa cases and 1,006 healthy controls were compared. Subjects were interviewed on major lifestyle factors and family history. Fifty-six PCa susceptibility SNPs were genotyped. Risk models based on logistic regression were developed to combine environmental factors, family history and a genetic risk score. In the whole model, compared with subjects with low risk (reference category, decile 1), those carrying an intermediate risk (decile 5) had a 265% increase in PCa risk (OR = 3.65, 95% CI 2.26 to 5.91). The genetic risk score had an area under the ROC curve (AUROC) of 0.66 (95% CI 0.63 to 0.68). When adding the environmental score and family history to the genetic risk score, the AUROC increased by 0.05, reaching 0.71 (95% CI 0.69 to 0.74). Genetic susceptibility has a stronger risk value of the prediction that modifiable risk factors. While the added value of each SNP is small, the combination of 56 SNPs adds to the predictive ability of the risk model.
Repisalud
Publicación Artículo científico (JournalArticle)

Chikungunya virus infections among travellers returning to Spain, 2008 to 2014

  • Fernandez-Garcia, Maria Dolores
  • Bangert, Mathieu
  • De Ory, Fernando de
  • Potente, Arantxa
  • Hernandez, Lourdes
  • Lasala, Fátima
  • Herrero-Romero, Laura
  • Molero-Sanz, Francisca
  • Negredo, Anabel
  • Vazquez, Ana
  • Minguito, Teodora
  • Balfagon, Pilar
  • Fuente, Jesus de la
  • Puente, Sabino
  • Ramirez de Arellano, Eva
  • Lago, Mar
  • Martinez, Miguel
  • Gascón, Joaquim
  • Norman, Francesca
  • López-Vélez, Rogelio
  • Sulleiro, Elena
  • Pou, Diana
  • Serre, Nuria
  • Fernández Roblas, Ricardo
  • Tenorio, Antonio
  • Franco, Leticia
  • Sánchez-Seco, María Paz
Since the first documented autochthonous transmission of chikungunya virus in the Caribbean island of Saint Martin in 2013, the infection has been reported within the Caribbean region as well as North, Central and South America. The risk of autochthonous transmission of chikungunya virus becoming established in Spain may be elevated due to the large numbers of travellers returning to Spain from countries affected by the 2013 epidemic in the Caribbean and South America, as well as the existence of the Aedes albopictus vector in certain parts of Spain. We retrospectively analysed the laboratory diagnostic database of the National Centre for Microbiology, Institute of Health Carlos III (CNM-ISCIII) from 2008 to 2014. During the study period, 264 confirmed cases, of 1,371 suspected cases, were diagnosed at the CNM-ISCIII. In 2014 alone, there were 234 confirmed cases. The highest number of confirmed cases were reported from the Dominican Republic (n = 136), Venezuela (n = 30) and Haiti (n = 11). Six cases were viraemic in areas of Spain where the vector is present. This report highlights the need for integrated active case and vector surveillance in Spain and other parts of Europe where chikungunya virus may be introduced by returning travellers.
Repisalud
Publicación Artículo científico (JournalArticle)

Social mobility and healthy behaviours from a gender perspective in the Spanish multicase-control study (MCC-Spain)

  • Pinto-Carbó, M
  • Peiró-Pérez, R
  • Molina-Barceló, Ana
  • Vanaclocha-Espi, Mercedes
  • Alguacil, Juan
  • Castaño-Vinyals, Gemma
  • O'Callaghan-Gordo, Cristina
  • Gràcia-Lavedan, Esther
  • Perez-Gomez, Beatriz
  • Lope Carvajal, Virginia
  • Aragones, Nuria
  • Molina, A J
  • Fernández-Villa, Tania
  • Gil-Majuelo, L
  • Amiano, P
  • Dierssen-Sotos, Trinidad
  • Gómez-Acebo, Inés
  • Guevara, M
  • Moreno-Iribas, C
  • Obón-Santacana, Mireia
  • Rodríguez-Suárez, M M
  • Salcedo-Bellido, I
  • Delgado-Parrilla, A
  • Marcos-Gragera, R
  • Chirlaque, María-Dolores
  • Kogevinas, M
  • Pollan-Santamaria, Marina
  • Salas, D
There is evidence for the influence of socioeconomic status (SES) on healthy behaviours but the effect of social mobility (SM) is not yet well known. This study aims to analyse the influence of origin and destination SES (O-SES and D-SES) and SM on healthy behaviours and co-occurrence, from an integrated gender and age perspective. Data were obtained from the controls of MCC-Spain between 2008-2013 (3,606 participants). Healthy behaviours considered: healthy diet, moderate alcohol consumption, non-smoking and physical activity. SM was categorized as stable high, upward, stable medium, downward or stable low. Binary and multinomial logistic regression models were adjusted. Those aged <65, with a low O-SES, D-SES and stable low SM are less likely to have healthy behaviours in the case of both women (physically active: OR = 0.65 CI = 0.45-0.94, OR = 0.71 CI = 0.52-0.98, OR = 0.61 CI = 0.41-0.91) and men (non-smokers: OR = 0.44 CI = 0.26-0.76, OR = 0.54 CI = 0.35-0.83, OR = 0.41 CI 0.24-0.72; physically active: OR = 0.57 CI = 0.35-0.92, OR = 0.64 CI = 0.44-0.95, OR = 0.53 CI = 0.23-0.87). However, for those aged ≥65, this probability is higher in women with a low O-SES and D-SES (non-smoker: OR = 8.09 CI = 4.18-15.67, OR = 4.14 CI = 2.28-7.52; moderate alcohol consumption: OR = 3.00 CI = 1.45-6.24, OR = 2.83 CI = 1.49-5.37) and in men with a stable low SM (physically active: OR = 1.52 CI = 1.02-1.26). In the case of men, the same behaviour pattern is observed in those with a low O-SES as those with upward mobility, with a higher probability of co-occurring behaviours (three-to-four behaviours: OR = 2.00 CI = 1.22-3.29; OR = 3.13 CI = 1.31-7.48). The relationship of O-SES, D-SES and SM with healthy behaviours is complex and differs according to age and gender.
Repisalud
Publicación Artículo científico (JournalArticle)

Cohort profile: the MCC-Spain follow-up on colorectal, breast and prostate cancers: study design and initial results

  • Alonso-Molero, Jéssica
  • Molina, Antonio J
  • Jimenez-Moleon, Jose J.
  • Perez-Gomez, Beatriz
  • Martín, Vicente
  • Moreno, Victor
  • Amiano, Pilar
  • Ardanaz, Eva
  • de Sanjose, Silvia
  • Salcedo, Inmaculada
  • Fernández-Tardón, Guillermo
  • Alguacil, Juan
  • Salas, Dolores
  • Marcos-Gragera, Rafael
  • Chirlaque, María-Dolores
  • Aragones, Nuria
  • Castaño-Vinyals, Gemma
  • Pollan-Santamaria, Marina
  • Kogevinas, Manolis
  • Llorca, Javier
PURPOSE: Since 2016, the multicase-control study in Spain (MCC-Spain) has focused towards the identification of factors associated with cancer prognosis. Inception cohorts of patients with colorectal, breast and prostate cancers were assembled using the incident cases originally recruited. PARTICIPANTS: 2140 new cases of colorectal cancer, 1732 of breast cancer and 1112 of prostate cancer were initially recruited in 12 Spanish provinces; all cancers were incident and pathologically confirmed. Follow-up was obtained for 2097 (98%), 1685 (97%) and 1055 (94.9%) patients, respectively. FINDINGS TO DATE: Information gathered at recruitment included sociodemographic factors, medical history, lifestyle and environmental exposures. Biological samples were obtained, and 80% of patients were genotyped using a commercial exome array. The follow-up was performed by (1) reviewing medical records; (2) interviewing the patients by phone on quality of life; and (3) verifying vital status and cause of death in the Spanish National Death Index. Ninety-seven per cent of recruited patients were successfully followed up in 2017 or 2018; patient-years of follow-up were 30 914. Most colorectal cancers (52%) were at clinical stage II or lower at recruitment; 819 patients died in the follow-up and the 5-year survival was better for women (74.4%) than men (70.0%). 71% of breast cancers were diagnosed at stages I or II; 206 women with breast cancer died in the follow-up and the 5-year survival was 90.7%. 49% of prostate cancers were diagnosed at stage II and 32% at stage III; 119 patients with prostate cancer died in the follow-up and the 5-year survival was 93.7%. FUTURE PLANS: MCC-Spain has built three prospective cohorts on highly frequent cancers across Spain, allowing to investigate socioeconomic, clinical, lifestyle, environmental and genetic variables as putative prognosis factors determining survival of patients of the three cancers and the inter-relationship of these factors.
Repisalud
Publicación Artículo científico (JournalArticle)

Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study

  • Dierssen-Sotos, Trinidad
  • Gómez-Acebo, Inés
  • de Pedro, María
  • Perez-Gomez, Beatriz
  • Servitja, Sonia
  • Moreno, Victor
  • Amiano, Pilar
  • Fernandez-Villa, Tania
  • Barricarte, Aurelio
  • Tardón, Adonina
  • Diaz-Santos, Marian
  • Peiró-Pérez, Rosana
  • Marcos-Gragera, Rafael
  • Lope Carvajal, Virginia
  • Gràcia-Lavedan, Esther
  • Alonso, María Henar
  • Michelena-Echeveste, Maria Jesus
  • Garcia-Palomo, Andrés
  • Guevara, Marcela
  • Castaño-Vinyals, Gemma
  • Aragones, Nuria
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Llorca, Javier
BACKGROUND: The relationship between non-steroidal antiinflammatory drug (NSAID) consumption and breast cancer has been repeatedly studied, although the results remain controversial. Most case-control studies reported that NSAID consumption protected against breast cancer, while most cohort studies did not find this effect. Most studies have dealt with NSAIDs as a whole group or with specific drugs, such aspirin, ibuprofen, or others, but not with NSAID subgroups according to the Anatomical Therapeutic Chemical Classification System; moreover, scarce attention has been paid to their effect on different tumor categories (i.e.: ductal/non-ductal, stage at diagnosis or presence of hormonal receptors). METHODS: In this case-control study, we report the NSAID - breast cancer relationship in 1736 breast cancer cases and 1895 healthy controls; results are reported stratifying by the women's characteristics (i.e.: menopausal status or body mass index category) and by tumor characteristics. RESULTS: In our study, NSAID use was associated with a 24 % reduction in breast cancer risk (Odds ratio [OR] = 0.76; 95 % Confidence Interval [CI]: 0.64-0.89), and similar results were found for acetic acid derivatives, propionic acid derivatives and COXIBs, but not for aspirin. Similar results were found in postmenopausal and premenopausal women. NSAID consumption also protected against hormone + or HER2+ cancers, but not against triple negative breast cancers. The COX-2 selectivity showed an inverse association with breast cancer (i.e. OR < 1), except in advanced clinical stage and triple negative cancers. CONCLUSION: Most NSAIDs, but not aspirin, showed an inverse association against breast cancer; this effect seems to be restricted to hormone + or HER2+ cancers.
Repisalud
Publicación Artículo científico (JournalArticle)

Mendelian randomization analysis rules out disylipidaemia as colorectal cancer cause

  • Ibáñez-Sanz, Gemma
  • Díez-Villanueva, Anna
  • Riera-Ponsati, Marina
  • Fernández-Villa, Tania
  • Fernandez-Navarro, Pablo L
  • Bustamante, Mariona
  • Llorca, Javier
  • Amiano, Pilar
  • Ascunce, Nieves
  • Fernández-Tardón, Guillermo
  • Salcedo Bellido, Inmaculada
  • Salas, Dolores
  • Capelo Álvarez, Rocío
  • Crous-Bou, Marta
  • Ortega-Valín, Luis
  • Perez-Gomez, Beatriz
  • Castaño-Vinyals, Gemma
  • Palazuelos, Camilo
  • Altzibar, Jone M
  • Ardanaz, Eva
  • Tardón, Adonina
  • Jimenez-Moleon, Jose J.
  • Olmos Juste, Valle
  • Aragones, Nuria
  • Pollan-Santamaria, Marina
  • Kogevinas, Manolis
  • Moreno, Victor
Dyslipidemia and statin use have been associated with colorectal cancer (CRC), but prospective studies have shown mixed results. We aimed to determine whether dyslipidemia is causally linked to CRC risk using a Mendelian randomization approach and to explore the association of statins with CRC. A case-control study was performed including 1336 CRC cases and 2744 controls (MCC-Spain). Subjects were administered an epidemiological questionnaire and were genotyped with an array which included polymorphisms associated with blood lipids levels, selected to avoid pleiotropy. Four genetic lipid scores specific for triglycerides (TG), high density lipoprotein cholesterol (HDL), low density lipoprotein cholesterol (LDL), or total cholesterol (TC) were created as the count of risk alleles. The genetic lipid scores were not associated with CRC. The ORs per 10 risk alleles, were for TG 0.91 (95%CI: 0.72-1.16, p = 0.44), for HDL 1.14 (95%CI: 0.95-1.37, p = 0.16), for LDL 0.97 (95%CI: 0.81-1.16, p = 0.73), and for TC 0.98 (95%CI: 0.84-1.17, p = 0.88). The LDL and TC genetic risk scores were associated with statin use, but not the HDL or TG. Statin use, overall, was a non-significant protective factor for CRC (OR 0.84; 95%CI: 0.70-1.01, p = 0.060), but lipophilic statins were associated with a CRC risk reduction (OR 0.78; 95%CI 0.66-0.96, p = 0.018). Using the Mendelian randomization approach, our study does not support the hypothesis that lipid levels are associated with the risk of CRC. This study does not rule out, however, a possible protective effect of statins in CRC by a mechanism unrelated to lipid levels.
Repisalud
Publicación Artículo científico (JournalArticle)

First report of sylvatic DENV-2-associated dengue hemorrhagic fever in West Africa

  • Franco, Leticia
  • Palacios, Gustavo
  • Martinez, José Antonio
  • Vazquez, Ana
  • Savji, Nazir
  • De Ory, Fernando de
  • Sánchez-Seco, María Paz
  • Martín, Dolores
  • Lipkin, W Ian
  • Tenorio, Antonio
Dengue virus (DENV) circulates in human and sylvatic cycles. Sylvatic strains are both ecologically and evolutionarily distinct from endemic viruses. Although sylvatic dengue cycles occur in West African countries and Malaysia, only a few cases of mild human disease caused by sylvatic strains and one single case of dengue hemorrhagic fever in Malaysia have been reported. Here we report a case of dengue hemorrhagic fever (DHF) with thrombocytopenia (13000/µl), a raised hematocrit (32% above baseline) and mucosal bleeding in a 27-year-old male returning to Spain in November 2009 after visiting his home country Guinea Bissau. Sylvatic DENV-2 West African lineage was isolated from blood and sera. This is the first case of DHF associated with sylvatic DENV-2 in Africa and the second case worldwide of DHF caused by a sylvatic strain.
Repisalud
Publicación Artículo científico (JournalArticle)

Burden of postmenopausal breast cancer attributable to excess body weight: comparative study of body mass index and CUN-BAE in MCC-Spain study

  • Cubelos-Fernández, Naiara
  • Dávila-Batista, Verónica
  • Fernández-Villa, Tania
  • Castaño-Vinyals, Gemma
  • Perez-Gomez, Beatriz
  • Amiano, Pilar
  • Ardanaz, Eva
  • Delgado Sillero, Irene
  • Llorca, Javier
  • Tardón, Guillermo Fernández
  • Alguacil, Juan
  • Vanaclocha-Espi, Mercedes
  • Marcos-Gragera, Rafael
  • Moreno, Victor
  • Aragones, Nuria
  • Dorronsoro, Ane
  • Guevara, Marcela
  • Reguero Celada, Sofía
  • Pollan-Santamaria, Marina
  • Kogevinas, Manolis
  • Martín, Vicente
Background: 10% of postmenopausal breast cancer cases are attributed to a high body mass index (BMI). BMI underestimates body fat, particularly in older women, and therefore the cancer burden attributable to obesity may be even higher. However, this is not clear. CUN-BAE (Clínica Universidad de Navarra-Body Adiposity Estimator) is an accurate validated estimator of body fat, taking into account sex and age. The objective of this study was to compare the burden of postmenopausal breast cancer attributable to excess body fat calculated using BMI and CUN-BAE. Methods: This case-control study included 1033 cases of breast cancer and 1143 postmenopausal population controls from the multicase-control MCC-Spain study. Logistic regression models were used to calculate odds ratios (ORs). The population attributable fraction (PAF) of excess weight related to breast cancer was estimated with both anthropometric measures. Stratified analyses were carried out for hormone receptor type. Results: Excess body weight attributable to the risk of breast cancer was 23.0% when assessed using a BMI value ≥30 kg/m2 and 38.0% when assessed using a CUN-BAE value of ≥40% body fat. Hormone receptor stratification showed that these differences in PAFs were only observed in hormone receptor positive cases, with an estimated burden of 19.9% for BMI and 41.9% for CUN-BAE. Conclusion: These findings suggest that the significance of excess body fat in postmenopausal hormone receptor positive breast cancer could be underestimated when assessed using only BMI. Accurate estimation of the cancer burden attributable to obesity is crucial for planning effective prevention initiatives.
Repisalud
Publicación Artículo científico (JournalArticle)

Dietary Inflammatory Index, Dietary Non-Enzymatic Antioxidant Capacity, and Colorectal and Breast Cancer Risk (MCC-Spain Study)

  • Obón-Santacana, Mireia
  • Romaguera, Dora
  • Gràcia-Lavedan, Esther
  • Molinuevo, Amaia
  • Molina-Montes, Esther
  • Shivappa, Nitin
  • Hebert, James R
  • Tardón, Adonina
  • Castaño-Vinyals, Gemma
  • Moratalla, Ferran
  • Guinó, Elisabet
  • Marcos-Gragera, Rafael
  • Azpiri, Mikel
  • Gil, Leire
  • Olmedo-Requena, Rocío
  • Lozano-Lorca, Macarena
  • Alguacil, Juan
  • Fernández-Villa, Tania
  • Martín, Vicente
  • Molina, Antonio J
  • Ederra, María
  • Moreno-Iribas, Conchi
  • Perez-Gomez, Beatriz
  • Aragones, Nuria
  • Castelló Pastor, Adela
  • Huerta, José María
  • Dierssen-Sotos, Trinidad
  • Gómez-Acebo, Inés
  • Molina-Barceló, Ana
  • Pollan-Santamaria, Marina
  • Kogevinas, Manolis
  • Moreno, Victor
  • Amiano, Pilar
Inflammation and antioxidant capacity have been associated with colorectal and breast cancer. We computed the dietary inflammatory index (DII®), and the total dietary non-enzymatic antioxidant capacity (NEAC) and associated them with colorectal and breast cancer risk in the population-based multi case-control study in Spain (MCC-Spain). We included 1852 colorectal cancer and 1567 breast cancer cases, and 3447 and 1486 population controls, respectively. DII score and NEAC were derived using data from a semi-quantitative validated food frequency questionnaire. Unconditional logistic regression models were used to estimate odds ratios (OR) and 95% confidence intervals (95%CI) for energy-adjusted DII (E-DII), and a score combining E-DII and NEAC. E-DII was associated with colorectal cancer risk (OR = 1.93, highest quartile versus lowest, 95%CI:1.60-2.32; p-trend: <0.001); this increase was observed for both colon and rectal cancer. Less pronounced increased risks were observed for breast cancer (OR = 1.22, highest quartile versus lowest, 95%CI:0.99-1.52, p-trend: >0.10). The combined score of high E-DII scores and low antioxidant values were associated with colorectal cancer risk (OR = 1.48, highest quartile versus lowest, 95%CI: 1.26-1.74; p-trend: <0.001), but not breast cancer. This study provides evidence that a pro-inflammatory diet is associated with increased colorectal cancer risk while findings for breast cancer were less consistent.
Repisalud
Publicación Artículo científico (JournalArticle)

Adequacy of early-stage breast cancer systemic adjuvant treatment to Saint Gallen-2013 statement: the MCC-Spain study

  • Gómez-Acebo, Inés
  • Dierssen-Sotos, Trinidad
  • Mirones, Mónica
  • Perez-Gomez, Beatriz
  • Guevara, Marcela
  • Amiano, Pilar
  • Sala, María
  • Molina, Antonio J
  • Alonso-Molero, Jéssica
  • Moreno, Victor
  • Suarez-Calleja, Claudia
  • Molina-Barceló, Ana
  • Alguacil, Juan
  • Marcos-Gragera, Rafael
  • Fernández-Ortiz, María
  • Sanz-Guadarrama, Oscar
  • Castaño-Vinyals, Gemma
  • Gil-Majuelo, Leire
  • Moreno-Iribas, Conchi
  • Aragones, Nuria
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Llorca, Javier
The St Gallen Conference endorsed in 2013 a series of recommendations on early breast cancer treatment. The main purpose of this article is to ascertain the clinical factors associated with St Gallen-2013 recommendations accomplishment. A cohort of 1152 breast cancer cases diagnosed with pathological stage < 3 in Spain between 2008 and 2013 was begun and then followed-up until 2017/2018. Data on patient and tumour characteristics were obtained from medical records, as well as their first line treatment. First line treatments were classified in three categories, according on whether they included the main St Gallen-2013 recommendations, more than those recommended or less than those recommended. Multinomial logistic regression models were carried out to identify factors associated with this classification and Weibull regression models were used to find out the relationship between this classification and survival. About half of the patients were treated according to St Gallen recommendations; 21% were treated over what was recommended and 33% received less treatment than recommended. Factors associated with treatment over the recommendations were stage II (relative risk ratio [RRR] = 4.2, 2.9-5.9), cancer positive to either progesterone (RRR = 8.1, 4.4-14.9) or oestrogen receptors (RRR = 5.7, 3.0-11.0). Instead, factors associated with lower probability of treatment over the recommendations were age (RRR = 0.7 each 10 years, 0.6-0.8), poor differentiation (RRR = 0.09, 0.04-0.19), HER2 positive (RRR = 0.46, 0.26-0.81) and triple negative cancer (RRR = 0.03, 0.01-0.11). Patients treated less than what was recommended in St Gallen had cancers in stage 0 (RRR = 21.6, 7.2-64.5), poorly differentiated (RRR = 1.9, 1.2-2.9), HER2 positive (RRR = 3.4, 2.4-4.9) and luminal B-like subtype (RRR = 3.6, 2.6-5.1). Women over 65 years old had a higher probability of being treated less than what was recommended if they had luminal B-like, HER2 or triple negative cancer. Treatment over St Gallen was associated with younger women and less severe cancers, while treatment under St Gallen was associated with older women, more severe cancers and cancers expressing HER2 receptors.
Repisalud
Publicación Artículo científico (JournalArticle)

Alkylphenolic compounds and risk of breast and prostate cancer in the MCC-Spain study

  • Peremiquel-Trillas, Paula
  • Benavente, Yolanda
  • Martín-Bustamante, Mayte
  • Casabonne, Delphine
  • Perez-Gomez, Beatriz
  • Gómez-Acebo, Inés
  • Oliete-Canela, Anna
  • Diéguez-Rodríguez, Marta
  • Tusquets, Ignasi
  • Amiano, Pilar
  • Mengual, Lourdes
  • Ardanaz, Eva
  • Capelo, Rocío
  • Molina de la Torre, Antonio J
  • Salas-Trejo, Dolores
  • Fernández-Tardón, Guillermo
  • Lope Carvajal, Virginia
  • Jimenez-Moleon, Jose J.
  • Marcos-Gragera, Rafael
  • Dierssen-Sotos, Trinidad
  • Azpiri, Mikel
  • Muñoz, Montse
  • Guevara, Marcela
  • Fernández-Villa, Tania
  • Molina-Barceló, Ana
  • Aragones, Nuria
  • Pollan-Santamaria, Marina
  • Castaño-Vinyals, Gemma
  • Alguacil, Juan
  • Kogevinas, Manolis
  • de Sanjose, Silvia
  • Costas, Laura
BACKGROUND: Alkylphenolic compounds are chemicals with endocrine disrupting properties that have been widely used in industry with important changes in their usage over time. Few epidemiologic studies have evaluated the effect of alkylphenolic compounds on human health. OBJECTIVES: We investigated whether occupational exposure to alkylphenolic compounds is associated with breast and prostate cancer. METHODS: We carried out a population-based case-control study including 1513 incident cases of breast cancer, 1095 of prostate cancer, and 3055 controls, frequency matched by sex, age and region. Occupational exposure to alkylphenolic compounds was estimated using a recently developed job-exposure matrix, which considered different scenarios of exposure and different subtypes of alkylphenolic compounds. RESULTS: History of occupational exposure to alkylphenolic compounds was modestly associated with breast cancer (OR = 1.23; 95% CI = 1.01-1.48). Within the different scenarios, the occupational use of domestic tensioactives was positively associated with breast cancer (OR = 1.28; 95% CI = 1.02-1.60), while occupational exposure in other scenarios showed mostly a suggestion of a similar positive associations. Exposure to nonylphenol ethoxylates was positively associated with breast cancer (OR = 1.21; 95% CI = 1.00-1.47), while exposure to other compounds was uncommon. In general, we did not observe associations between alkylphenolic compounds and prostate cancer, except for a positive association among men occupationally exposed to cosmetic, hair and personal hygiene products. CONCLUSIONS: Our findings suggest a modest association between breast cancer risk and occupational exposure to alkylphenolic compounds, and no associations between these compounds and prostate cancer risk. These findings warrant further corroboration in other studies.
Repisalud
Publicación Artículo científico (JournalArticle)

Exosomes promote restoration after an experimental animal model of intracerebral hemorrhage

  • Otero-Ortega, Laura
  • Gómez de Frutos, Mari Carmen
  • Laso-García, Fernando
  • Rodríguez-Frutos, Berta
  • Medina-Gutiérrez, Esperanza
  • Lopez, Juan Antonio
  • Vazquez, Jesus
  • Díez-Tejedor, Exuperio
  • Gutiérrez-Fernández, María
Exosomes are gaining importance because they show great promise in therapeutic applications for several diseases. Particularly in stroke, exosomes derived from mesenchymal stem cell (MSC) therapy work as paracrine effectors responsible for promoting neurovascular remodeling and functional recovery. Adult male rats were subjected to intracerebral hemorrhage (ICH) by intrastriatal injection of collagenase type IV; 24 h after surgery, MSC-derived exosomes were administered through the tail vein. The rats were euthanized at 7 or 28 days after treatment. Functional evaluation, lesion size, fiber tract integrity, axonal sprouting and white matter repair markers, biodistribution of exosomes and secretome proteomics were analyzed. DiI-labeled exosomes were found in the brains of the ICH-treated group and in the liver, lung and spleen. Animals receiving treatment with exosomes showed significantly better results in terms of functional recovery, lesion size, fiber tract integrity, axonal sprouting and white matter repair markers compared with the control group 28 days after stroke. Proteomics analysis of the exosomes identified more than 2000 proteins that could be implicated in brain repair function. In conclusion, white matter integrity was partly restored by exosome administration mediated by molecular repair factors. Exosomes as a treatment could be a heterogeneous process by nature and presents many factors that can influence brain plasticity in an adaptable and versatile manner.
Repisalud
Publicación Artículo científico (JournalArticle)

Dietary Constituents: Relationship with Breast Cancer Prognostic (MCC-SPAIN Follow-Up)

  • Dierssen-Sotos, Trinidad
  • Gómez-Acebo, Inés
  • Gutiérrez-Ruiz, Nuria
  • Aragones, Nuria
  • Amiano, Pilar
  • Molina de la Torre, Antonio José
  • Guevara, Marcela
  • Alonso-Molero, Jéssica
  • Obón-Santacana, Mireia
  • Fernández-Tardón, Guillermo
  • Molina-Barceló, Ana
  • Alguacil, Juan
  • Marcos-Gragera, Rafael
  • Rodríguez-Cundín, Paz
  • Castaño-Vinyals, Gemma
  • Canseco Fernandez, Rosario
  • Castilla Catalán, Jesús
  • Molinuevo, Amaia
  • Perez-Gomez, Beatriz
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Llorca, Javier
The aim of this study was to characterize the relationship between the intake of the major nutrients and prognosis in breast cancer. A cohort based on 1350 women with invasive (stage I-IV) breast cancer (BC) was followed up. Information about their dietary habits before diagnosis was collected using a semi-quantitative Food Frequency Questionnaire. Participants without FFQ or with implausible energy intake were excluded. The total amount consumed of each nutrient (Kcal/day) was divided into tertiles, considering as "high intakes" those above third tertile. The main effect studied was overall survival. Cox regression was used to assess the association between death and nutrient intake. During a median follow-up of 6.5 years, 171 deaths were observed. None of the nutrients analysed was associated with mortality in the whole sample. However, in normal-weight women (BMI 18.5-25 kg/m2) a high intake of carbohydrates (≥809 Kcal/day), specifically monosaccharides (≥468 Kcal/day), worsened prognostic compared to lowest (≤352 Kcal/day). Hazard Ratios (HRs) for increasing tertiles of intake were HR:2.22 95% CI (1.04 to 4.72) and HR:2.59 95% CI (1.04 to 6.48), respectively (p trend = 0.04)). Conversely, high intakes of polyunsaturated fats (≥135 Kcal/day) improved global survival (HR: 0.39 95% CI (0.15 to 1.02) p-trend = 0.05) compared to the lowest (≤92.8 kcal/day). In addition, a protective effect was found substituting 100 kcal of carbohydrates with 100 kcal of fats in normal-weight women (HR: 0.76 95% CI (0.59 to 0.98)). Likewise, in premenopausal women a high intake of fats (≥811 Kcal/day) showed a protective effect (HR:0.20 95% CI (0.04 to 0.98) p trend = 0.06). Finally, in Estrogen Receptors (ER) negative tumors, we found a protective effect of high intake of animal proteins (≥238 Kcal/day, HR: 0.24 95% CI (0.06 to 0.98). According to our results, menopausal status, BMI and ER status could play a role in the relationship between diet and BC survival and must be taken into account when studying the influence of different nutrients.
Repisalud
Publicación Artículo científico (JournalArticle)

Risk Model for Colorectal Cancer in Spanish Population Using Environmental and Genetic Factors: Results from the MCC-Spain study

  • Ibáñez-Sanz, Gemma
  • Díez-Villanueva, Anna
  • Alonso, María Henar
  • Rodríguez-Moranta, Francisco
  • Perez-Gomez, Beatriz
  • Bustamante, Mariona
  • Martín, Vicente
  • Llorca, Javier
  • Amiano, Pilar
  • Ardanaz, Eva
  • Tardón, Adonina
  • Jimenez-Moleon, Jose J.
  • Peiró, Rosana
  • Alguacil, Juan
  • Navarro Rivas, Carmen
  • Guinó, Elisabet
  • Binefa, Gemma
  • Fernandez-Navarro, Pablo L
  • Espinosa, Anna
  • Dávila-Batista, Verónica
  • Molina, Antonio José
  • Palazuelos, Camilo
  • Castaño-Vinyals, Gemma
  • Aragones, Nuria
  • Kogevinas, Manolis
  • Moreno, Victor
  • Pollan-Santamaria, Marina
Colorectal cancer (CRC) screening of the average risk population is only indicated according to age. We aim to elaborate a model to stratify the risk of CRC by incorporating environmental data and single nucleotide polymorphisms (SNP). The MCC-Spain case-control study included 1336 CRC cases and 2744 controls. Subjects were interviewed on lifestyle factors, family and medical history. Twenty-one CRC susceptibility SNPs were genotyped. The environmental risk model, which included alcohol consumption, obesity, physical activity, red meat and vegetable consumption, and nonsteroidal anti-inflammatory drug use, contributed to CRC with an average per factor OR of 1.36 (95% CI 1.27 to 1.45). Family history of CRC contributed an OR of 2.25 (95% CI 1.87 to 2.72), and each additional SNP contributed an OR of 1.07 (95% CI 1.04 to 1.10). The risk of subjects with more than 25 risk alleles (5th quintile) was 82% higher (OR 1.82, 95% CI 1.11 to 2.98) than subjects with less than 19 alleles (1st quintile). This risk model, with an AUROC curve of 0.63 (95% CI 0.60 to 0.66), could be useful to stratify individuals. Environmental factors had more weight than the genetic score, which should be considered to encourage patients to achieve a healthier lifestyle.
Repisalud
Publicación Artículo científico (JournalArticle)

Quality of Life in a Cohort of 1078 Women Diagnosed with Breast Cancer in Spain: 7-Year Follow-Up Results in the MCC-Spain Study

  • Alonso-Molero, Jéssica
  • Dierssen-Sotos, Trinidad
  • Gómez-Acebo, Inés
  • Fernandez de Larrea-Baz, Nerea
  • Guevara, Marcela
  • Amiano, Pilar
  • Castaño-Vinyals, Gemma
  • Fernández-Villa, Tania
  • Moreno, Victor
  • Bayo, Juan
  • Molina-Barceló, Ana
  • Fernández-Ortíz, María
  • Suarez-Calleja, Claudia
  • Marcos-Gragera, Rafael
  • Castells, Xavier
  • Gil-Majuelo, Leire
  • Ardanaz, Eva
  • Perez-Gomez, Beatriz
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Llorca, Javier
Breast cancer is the most frequent cause of tumors and net survival is increasing. Achieving a higher survival probability reinforces the importance of studying health-related quality of life (HR-QoL). The main aim of this work is to test the relationship between different sociodemographic, clinical and tumor-intrinsic characteristics, and treatment received with HR-QoL measured using SF-12 and the FACT/NCCN (National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy) Breast Symptom Index (FBSI). Women with breast cancer recruited between 2008 and 2013 and followed-up until 2017-2018 in a prospective cohort answered two HR-QoL surveys: the SF-12 and FBSI. The scores obtained were related to woman and tumor characteristics using linear regression models. The telephone survey was answered by 1078 women out of 1685 with medical record follow-up (64%). Increases in all three HR-QoL scores were associated with higher educational level. The score differences between women with university qualifications and women with no schooling were 5.43 for PCS-12, 6.13 for MCS-12 and 4.29 for FBSI. Histological grade at diagnosis and recurrence in the follow-up displayed a significant association with mental and physical HR-QoL, respectively. First-line treatment received was not associated with HR-QoL scores. On the other hand, most tumor characteristics were not associated with HR-QoL. As breast cancer survival is improving, further studies are needed to ascertain if these differences still hold in the long run.
Repisalud
Publicación Artículo científico (JournalArticle)

Flavonoids and the Risk of Gastric Cancer: An Exploratory Case-Control Study in the MCC-Spain Study

  • Vitelli-Storelli, Facundo
  • Molina, Antonio José
  • Zamora-Ros, Raúl
  • Fernández-Villa, Tania
  • Roussou, Vasiliki
  • Romaguera, Dora
  • Aragones, Nuria
  • Obón-Santacana, Mireia
  • Guevara, Marcela
  • Gómez-Acebo, Inés
  • Fernández-Tardón, Guillermo
  • Molina-Barceló, Ana
  • Olmedo-Requena, Rocío
  • Capelo, Rocío
  • Chirlaque, María-Dolores
  • Perez-Gomez, Beatriz
  • Moreno, Victor
  • Castilla Catalán, Jesús
  • Rubín-García, María
  • Pollan-Santamaria, Marina
  • Kogevinas, Manolis
  • Lera, Juan Pablo Barrio
  • Martín, Vicente
Several epidemiological studies have investigated the association between the dietary flavonoid intake and gastric cancer (GC) risk; however, the results remain inconclusive. Investigating the relationship between the different classes of flavonoids and the histological types and origin of GC can be of interest to the research community. We used data from a population-based multi-case control study (MCC-Spain) obtained from 12 different regions of Spain. 2700 controls and 329 GC cases were included in this study. Odds ratios (ORs) were calculated using the mixed effects logistic regression considering quartiles of flavonoid intakes and log2. Flavonoid intake was associated with a lower GC risk (ORlog2 = 0.76; 95% CI = 0.65-0.89; ORq4vsq1 = 0.60; 95%CI = 0.40-0.89; ptrend = 0.007). Inverse and statistically significant associations were observed with anthocyanidins, chalcones, dihydroflavonols and flavan-3-ols. The isoflavanoid intake was positively associated with higher cancer risk, but without reaching a statistical significance. In general, no differences were observed in the GC risk according to the location and histological type. The flavonoid intake seems to be a protective factor against GC within the MCC-study. This effect may vary depending on the flavonoid class but not by the histological type and location of the tumor. Broader studies with larger sample size and greater geographical variability are necessary.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A hypervalent metal MOF catalyst as an avenue to go beyond heterogeneous Fenton-like processes for organic contaminant removal in water

  • Santos-Juanes Jordá, Lucas|||0000-0001-5539-8341
  • Arqués Sanz, Antonio|||0000-0001-8692-6979
  • Rodriguez-Sanchez, Noelia
  • Balestra, Salvador R. G.
  • Núñez, Nuria O.
  • Ruiz-Salvador, A. Rabdel
  • Ballesteros, Menta
[EN] Metal-organic frameworks (MOFs) have recently been proposed as a plausible solution to the pressing issue of water scarcity and as a means of remediating contaminated water bodies. In light-assisted water treatment, they have so far only been exploited via the hydroxyl radical route, through Fenton-like processes. A new avenue is introduced here by the biomimetic conceptual design of MOF bearing hypervalent metal atoms for photocatalytic water treatment. We report a zeolitic imidazole framework (ZIF) material doped with iron (Fe-ZIF-7-III; UPO-4) synthesized via a novel mild treatment to stabilize photoactive hypervalent ferryl ions for the first time in a MOF for water treatment. The successful synthesis of the 2D material and the adequate incorporation of iron into the structure were demonstrated using X-ray diffraction (XRD), Fourier-transform infrared (FTIR) spectroscopy, and scanning electron microscopy (SEM). A simulation study analyzed the structure and stability of the Fe-ZIF-7-III material as well as the involvement of ferryl ions in the photo-Fenton-type process. Furthermore, the calculated band gap of this material shows its viability for use in photocatalysis using sunlight. This was confirmed by evaluating the photodegradation of caffeine, a model pollutant in water, without the assistance of hydroxyl radicals as indicated by a scavenger test. The recyclability test revealed that Fe-ZIF-7-III could be used continuously with effective catalytic activity, thus opening the door to the field of studying hypervalent metal MOFs not yet explored in water treatment., This work was supported by Spanish Ministerio de Ciencia e Innovacion (PID2021-126400OB-C31, AquaEnAgri Project) and the European Commission (HORIZON.1.2 - Marie Sklodowska-Curie Actions VALZEO Project 101086354). Salvador R. G. Balestra also thanks Consejeria de Universidades, Investigacion e Innovacion, Junta de Andalucia (grant number: POSTDOC_21_00069). We are grateful to C3UPO for providing high performance computing facilities.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Assessing Ploidy Level Analysis and Single Pollen Genotyping of Diploid and Euploid Citrus Genotypes by Fluorescence-Activated Cell Sorting and Whole-Genome Amplification

  • Garavello, Miguel
  • Cuenca, José
  • Dreissig, Steven
  • Fuchs, Jörg
  • Houben, Andreas
  • Aleza, Pablo
[EN] Flow cytometry is widely used to determine genome size and ploidy level in plants. This technique, when coupled with fluorescence-activated cell sorting (FACS), whole genome amplification and genotyping (WGA), opens up new opportunities for genetic studies of individualized nuclei. This strategy was used to analyze the genetic composition of single pollen nuclei of different citrus species. The flow cytometry and microscope observations allowed us to differentiate the populations of pollen nuclei present in the diploid and euploid genotypes analyzed, showing that citrus has binuclear pollen. We have identified in the ¿CSO¿ tangor an additional nuclei population composed by the vegetative plus generative nuclei. Genotyping of this nuclei population revealed that vegetative and generative nuclei show the same genetic configuration. In addition, we have demonstrated the presence of unreduced gametes in the diploid genotype ¿Mexican lime.¿ Genomic amplification is a robust method for haploid nuclei genotyping with several molecular markers, whereas in diploid nuclei using heterozygous markers showed a bias towards one of the two alleles, limiting the use of this tool in this type of nuclei. We further discuss the importance and applications of single pollen genotyping in citrus genetic studies., This work was supported by the project RTA2015-00069-00-00 from the Ministry of Economía y Competividad and Instituto Nacional de Investigación y Tecnología Agraria y Agroalimentaria and the grant Programa de Perfeccionamiento resolution 1177/14 from Consejo Directivo of Instituto Nacional de Tecnología Agropecuaria (Argentina).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Association of miR-126-3p, miR-1260b and miR-374a-5p with the incidence of heart failure in a population-based cohort: the Hortega Follow-Up Study

  • Grau-Perez, Maria
  • Martinez-Arroyo, Olga
  • Rubia-Martinez, Marta
  • Flores-Chova, Ana
  • Rodríguez-Hernández, Zulema
  • Fernández-Navarro, Pablo
  • Gonzalez-Neira, Anna
  • Alonso, María Rosario
  • Pita, Guillermo
  • Pineda, Silvia
  • Martin-Escudero, Juan C.
  • Redon, Josep
  • Tellez-Plaza, Maria
  • Cortes, Raquel
  • Guasque Ortega, Ana|||0000-0002-2900-8466
[EN] Background: Circulating microRNAs (miRNAs) are emerging markers for cardiovascular prevention and control. miRNAs associated to vascular damage are candidates to play a causal role in the microvascular dysfunction of heart failure (HF). The aim was to evaluate the observational and causal (Mendelian randomization) association of miRNAs related with vascular alterations (miR-126-3p, miR-1260b and miR-374a-5p) with HF incidence in a sample from the general population. Methods: Plasma miRNAs levels were measured in 985 Hortega Study participants using real time quantitative polymerase chain reaction (RT-qPCR). Single nucleotide polymorphisms (SNPs) were genotyped with the TOPMED imputable Illumina GSA array. We identified genetic instrumental variables for miR-126-3p (33 SNPs), miR-1260b (22 SNPs) and miR-374a-5p (35 SNPs) and run several Mendelian randomization approaches. Results: The hazard ratio (95 % confidence interval) of HF by a 10-fold increase in miR-126-3p, miR-1260b and miR-374a-5p was 1.53 (1.09, 2.14), 1.38 (1.03, 1.86), and1.30 (1.09, 1.57), respectively. The corresponding rate differences were 9.7 (-0.1, 19.5), 12.0 (0.4, 23.6) and 9.1 (1.2, 17.1) per 10000 person-years. In flexible dose-response analysis, increased miRNAs levels were associated with higher HF risk, both in the relative and additive scale. In Mendelian randomization analysis, consistently suggestive positive causal associations were found with HF for increased miR-126-3p and miR-1260b levels, but not for miR-374a-5p. Conclusions: In observational analysis, miR-126-3p, miR-1260b and miR-374a-5p levels were positively associ-ated with HF incidence. Mendelian randomization analysis supported a causal role for miR-126-3p and miR-1260b, thus suggesting a potential use as prognostic and therapeutic targets for HF prevention and control., We thank Nuria Alvarez y Belen Herraez, from the Human Genotyping-CEGEN Unit, at the National Center for Cancer Research from the Carlos III Health Institutes, in Madrid (Spain) , for their contribution in the genotyping procedure. This research was funded by health sciences research grants from the Carlos III Health Institute (grant numbers PI19/01796 to J.R.; PI21/00249 and CP22/00069 to R.C.; PI23/01179 to A.O.; FI20/00096 to O.M.-A; and FI22/00032 to A.F.-C.; PI15/00071 and PI22CIII/00029 to M.T.-P.) . This work was also sup-ported by the State Agency for Research (PID2019-108973RB-C21 to M. T.-P.) . Grant IJC2020-045308-I, Juan de la Cierva Incorporacion funded by MCIN/AEI/10.13039/501100011033 and by ESF-Investing in Your Future (to A.O.) ; CNS2022-136175, Research Consolidation Grants, funded by MCIN/AEI/10.13039/501100011033 and European Union "Next Generation EU"/PRTR" (to R.C) .; FP7-HEALTH 11 (grant number no 278249) . It was co-funded by the European Union (the European Regional Development Fund (ERDF) and the European Social Fund (FSE) ) ; CIBER of Obesity and Nutrition Physiopathology (CIBEROBN) (grant numbers CIBER-02-08-2009, CB06/03 and CB12/03/30016) . CIBER of Cardiovascular diseases (CIBERCV) (grant number CB16/11/00261) . CIBEROBN and CIBERCV are co-funded with European Funds for Regional Development (FEDER) , and IDIFEDER/2021/072, CIAICO/2022/181 and INVEST/2023/180 from the Generalitat Valenciana of Spain. Z.R.-H. received a fellowship associated to a Spain National Investigation Agency project (PRE2020-093926) . The genotyping service was carried out at the Genotyping Unit-CEGEN in the Spanish Na-tional Cancer Research Centre (CNIO) , supported by Instituto de Salud Carlos III (ISCIII) , Ministerio de Ciencia e Innovacion. CEGEN is part of the initiative IMPaCT GEN oMICA (IMP/00009) cofunded by ISCIII and the European Regional Development Fund (ERDF)
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Parthenocarpy and Self-Incompatibility in Mandarins

  • Montalt, Rafael
  • Vives, Mari Carmen
  • Navarro, Luis
  • Ollitrault, Patrick
  • Aleza, Pablo
[EN] Citrus reproductive biology is complex. One of its characteristic features is parthenocarpy that enables seedless fruit production. Citrus parthenocarpy and self-incompatibility knowledge is only partial and sometimes discrepant. Increasing such knowledge is relevant for better managing cultivated varieties and improving the selection of parents in breeding strategies to recover seedless varieties such as mandarins. This work develops an efficient protocol to characterize self-incompatibility and different parthenocarpy types based on emasculation, hand self-pollination, and hand cross-pollination. It analyzes fruit setting and seed production coupled with histological pollen performance observations. We analyzed the reproductive behavior of nine mandarin varieties with relevant characteristics as parents for seedless mandarin breeding. 'Clemenules' clementine and 'Moncada' mandarins were strictly self-incompatible with facultative and vegetative parthenocarpy; 'Imperial' mandarin and 'Ellendale' tangor displayed no strict self-incompatibility associated with facultative and vegetative parthenocarpy; 'Fortune' mandarin was self-incompatible with facultative and stimulative parthenocarpy; 'Campeona' and 'Saltenita' mandarins were self-compatible with vegetative parthenocarpy; 'Serafines' satsuma was associated with male sterility together with facultative and vegetative parthenocarpy; and 'Monreal' clementine was self-compatible and nonparthenocarpic. Our protocol can be applied for screening of mandarin germplasm and to characterize new parents. Reproductive behavior knowledge is important for optimizing seedless mandarin breeding programs based on diploidy, triploidy, or induced mutagenesis., This research was funded by Project RTA2015-00069-00-00 from the Spanish Ministry of "Economia y Competividad", and Fondo Europeo de Desarrollo Regional (FEDER).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Mechanism of the Low-Temperature Organic Removal from Imidazolium-Containing Zeolites by Ozone Treatment: Fluoride Retention in Double-4-Rings

  • Rei Gao, Zihao
  • Márquez-Álvarez, Carlos
  • Rodríguez-Gómez Balestra, Salvador
  • Yu, Huajian
  • Camblor, Miguel A.
  • Villaescusa Alonso, Luis Angel|||0000-0002-2720-3217
[EN] For zeolites synthesized using imidazolium cations, the organic matter can be extracted at very low temperatures (100 °C) using ozone. This is possible for zeolites with 12-ring or larger pores but requires higher temperatures in medium-pore zeolites. The first chemical events in this process occur fast, even at room temperature, and imply the loss of aromaticity likely by the formation of an adduct between ozone and the imidazole ring through carbons C4 and C5. Subsequent rupture of the imidazole ring provides smaller and more flexible fragments that can desorb more readily. This process has been studied experimentally, mainly through infrared spectroscopy, and theoretically by density functional theory. Amazingly, fluoride anions occluded in the small double-four-ring units (d4r) during the synthesis remain inside the cage throughout the whole process when the temperature is not too high (¿150 °C). However, fluoride in larger cages in MFI ends up bonded to silicon in penta or hexacoordinated units, likely out of the cages, after ozone treatment at 150 °C. For several germanosilicate zeolites, the process allows their subsequent degermanation to yield stable high-silica zeolites. Quaternary ammonium cations require harsher conditions that eventually also extract fluoride from zeolite cages, including the d4r unit., Grants PID2019-105479RB-I00, PID2022-138481NB-I00, PID2022-137889OB-I00, TED2021-131223B-I00, PID2021-128141OB-C22, and FJC2018-035697-I were funded by MCIN/AEI/10.13039/501100011033 and by the European Union NextGeneration EU/PRTR. M.A.C. thanks J. C. van der Waals for sharing unpublished information on his pioneering work. H.Y. is grateful to the China Scholarship Council (CSC) for a Ph.D. fellowship. S.R.G.B. also thanks the Consejeria de Universidades, Investigacion e Innovacion, Junta de Andalucia, for the POSTDOC_21_00069 grant.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

A systematic review on age-related macular degeneration: new insights from multi-omics studies

  • Castro Fernández, Diana Carolina
  • Cañizo Outeiriño, Antonio
  • Cuartero Martínez, Andrea
  • Gil Martínez, María
  • Mondelo García, Cristina
  • González Barcia, Miguel
  • Álvarez Barrios, Ana
  • Fernández Ferreiro, Anxo
Age-related macular degeneration (AMD) is a leading cause of blindness in developed countries and a growing global health concern. The multifactorial nature of AMD calls for integrative multi-omics approaches. We summarize studies employing multi-omics in AMD. A comprehensive search in PubMed and Scopus databases identified 561 records with multi-omics criteria, of which duplicates, unrelated and unavailable articles were excluded, resulting in 33 reports. Quality was assessed following the Office of Health Assessment and Translation (OHAT) method, and data was synthesized through standardized evidence tables. Across the reviewed reports, multi-omics approaches were applied to non-clinical and clinical samples, including ocular and systemic fluids. Methodological trends included the widespread use of causal inference approaches (e.g., Mendelian randomization and Bayesian colocalization) and increasing adoption of spatial and single-cell resolution techniques. Converging molecular patterns consistently suggested inflammation, complement activation, angiogenesis, lipid dysregulation, and mitochondrial dysfunction as key processes underlying AMD. Integration of genetic risk with proteomic and metabolomic alterations, enabled the identification of candidate diagnostic and prognostic biomarkers such as carboxyethylpyrrole and PRMT3. Additionally, this review revealed opportunities for personalized medicine in AMD patient stratification, improvement of prediction models, and therapeutic personalization; however, heterogeneity was noted across studies, particularly regarding sample source (systemic vs. ocular), analytical platforms, integration strategies, and ancestry representation. Despite this variability, this review illustrates how integrating multiple omics layers provides a comprehensive and multidimensional understanding of AMD pathology, advancing research towards better diagnosis, prognosis, and therapeutics for these patients.
ReDivia Repositorio Digital del Instituto Valenciano de Investigaciones Agrarias
Publicación Artículo científico (JournalArticle)

Strategies to produce grapefruit-like citrus varieties with a low furanocoumarin content and distinctive flavonoid profiles

  • García-Lor, Andrés
  • Bermejo, Almudena
  • Morales, Julia
  • Hernández, María
  • Medina, Alejandro
  • Cuenca, José
  • Navarro, Luis
  • Aleza, Pablo
Pummelos and hybrids, such as grapefruits, have high furanocoumarin and low flavonoid contents. Furanocoumarins interact negatively with certain drugs, while flavonoids are antioxidant compounds with health benefits. To obtain new grapefruit-like varieties with low furanocoumarin and high flavonoid contents, diploid and triploid hybrid populations from crosses between diploid and tetraploid “Clemenules” clementine and diploid “Pink” pummelo were recovered and analyzed. With regard to furanocoumarins, triploids produce less bergapten, bergamottin and 6,7-DHB than diploids. Regarding flavonoids, triploids yielded more eriocitrin, narirutin, hesperidin and neohesperidin than diploids, whereas no differences were observed in neoeriocitrin and naringin. These results indicate that, the strategy to recover triploid hybrids by 4x × 2x crosses is more appropriate than the recovery of diploid hybrids by 2x × 2x crosses for obtaining grapefruit-like varieties of citrus with lower furanocoumarin and higher flavonoid contents.
ReDivia Repositorio Digital del Instituto Valenciano de Investigaciones Agrarias
Publicación Artículo científico (JournalArticle)

Parthenocarpy and Self-Incompatibility in Mandarins

  • Montalt, Rafael
  • Vives, María C.
  • Navarro, Luis
  • Ollitrault, Patrick
  • Aleza, Pablo
Citrus reproductive biology is complex. One of its characteristic features is parthenocarpy that enables seedless fruit production. Citrus parthenocarpy and self-incompatibility knowledge is only partial and sometimes discrepant. Increasing such knowledge is relevant for better managing cultivated varieties and improving the selection of parents in breeding strategies to recover seedless varieties such as mandarins. This work develops an efficient protocol to characterize selfincompatibility and different parthenocarpy types based on emasculation, hand self-pollination, and hand cross-pollination. It analyzes fruit setting and seed production coupled with histological pollen performance observations. We analyzed the reproductive behavior of nine mandarin varieties with relevant characteristics as parents for seedless mandarin breeding. ‘Clemenules’ clementine and ‘Moncada’ mandarins were strictly self-incompatible with facultative and vegetative parthenocarpy; ‘Imperial’ mandarin and ‘Ellendale’ tangor displayed no strict self-incompatibility associated with facultative and vegetative parthenocarpy; ‘Fortune’ mandarin was self-incompatible with facultative and stimulative parthenocarpy; ‘Campeona’ and ‘Salteñita’ mandarins were self-compatible with vegetative parthenocarpy; ‘Serafines’ satsuma was associated with male sterility together with facultative and vegetative parthenocarpy; and ‘Monreal’ clementine was self-compatible and nonparthenocarpic. Our protocol can be applied for screening of mandarin germplasm and to characterize new parents. Reproductive behavior knowledge is important for optimizing seedless mandarin breeding programs based on diploidy, triploidy, or induced mutagenesis.
ReDivia Repositorio Digital del Instituto Valenciano de Investigaciones Agrarias
Publicación Artículo científico (JournalArticle)

Pollen Development and Viability in Diploid and Doubled Diploid Citrus Species

  • Lora, Jorge
  • García-Lor, Andrés
  • Aleza, Pablo
Seedlessness is one of the most important agronomic traits in mandarins on the fresh fruit market. Creation of triploid plants is an important breeding strategy for development of new commercial varieties of seedless citrus. To this end, one strategy is to perform sexual hybridizations, with tetraploid genotypes as male parents. However, while seed development has been widely studied in citrus, knowledge of key steps such as microsporogenesis and microgametogenesis, is scarce, especially in polyploids. Therefore, we performed a study on the effect of ploidy level on pollen development by including diploid and tetraploid (double diploid) genotypes with different degrees of pollen performance. A comprehensive study on the pollen ontogeny of diploid and doubled diploid “Sanguinelli” blood orange and “Clemenules” clementine was performed, with focus on pollen grain germination in vitro and in planta, morphology of mature pollen grains by scanning electron microscopy (SEM), cytochemical characterization of carbohydrates by periodic acid–Shiff staining, and specific cell wall components revealed by immunolocalization. During microsporogenesis, the main difference between diploid and doubled diploid genotypes was cell area, which was larger in doubled diploid genotypes. However, after increase in size and vacuolization of microspores, but before mitosis I, doubled diploid “Clemenules” clementine showed drastic differences in shape, cell area, and starch hydrolysis, which resulted in shrinkage of pollen grains. The loss of fertility in doubled diploid “Clemenules” clementine is mainly due to lack of carbohydrate accumulation in pollen during microgametogenesis, especially starch content, which led to pollen grain abortion. All these changes make the pollen of this genotype unviable and very difficult to use as a male parent in sexual hybridization with the objective of recovering large progenies of triploid hybrids.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Systemic CD4 immunity and PD-L1/PD-1 blockade immunotherapy

  • Escors Murugarren, David
  • Bocanegra Gondán, Ana Isabel
  • Chocarro de Erauso, Luisa
  • Blanco, Ester
  • Piñeiro Hermida, Sergio
  • Garnica, Maider
  • Fernández Rubio, Leticia
  • Vera García, Ruth
  • Arasanz Esteban, Hugo
  • Kochan, Grazyna
PD-L1/PD-1 blockade immunotherapy has changed the therapeutic approaches for the treatment of many cancers. Nevertheless, the mechanisms underlying its efficacy or treatment failure are still unclear. Proficient systemic immunity seems to be a prerequisite for efficacy, as recently shown in patients and in mouse models. It is widely accepted that expansion of anti-tumor CD8 T cell populations is principally responsible for anti-tumor responses. In contrast, the role of CD4 T cells has been less studied. Here we review and discuss the evidence supporting the contribution of CD4 T cells to anti-tumor immunity, especially recent advances linking CD4 T cell subsets to efficacious PD-L1/PD-1 blockade immunotherapy. We also discuss the role of CD4 T cell memory subsets present in peripheral blood before the start of immunotherapies, and their utility as predictors of response., The OncoImmunology group is funded by the Spanish Association against Cancer (AECC, PROYE16001ESCO); Instituto de Salud Carlos III (ISCIII)-FEDER project grants (FIS PI17/02119, FIS PI20/00010, COV20/00000, and TRANSPOCART ICI19/00069); a Biomedicine Project grant from the Department of Health of the Government of Navarre (BMED 050-2019); Strategic projects from the Department of Industry, Government of Navarre (AGATA, Ref 0011-1411-2020-000013; LINTERNA, Ref. 0011-1411-2020-000033; DESCARTHES, 0011-1411-2019-000058); This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 848166.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Leading edge: intratumor delivery of monoclonal antibodies for the treatment of solid tumors

  • Blanco, Ester
  • Chocarro de Erauso, Luisa
  • Fernández Rubio, Leticia
  • Bocanegra Gondán, Ana Isabel
  • Arasanz Esteban, Hugo
  • Echaide Górriz, Míriam
  • Garnica, Maider
  • Piñeiro Hermida, Sergio
  • Kochan, Grazyna
  • Escors Murugarren, David
Immunotherapies based on immune checkpoint blockade have shown remarkable clinical outcomes and durable responses in patients with many tumor types. Nevertheless, these therapies lack efficacy in most cancer patients, even causing severe adverse events in a small subset of patients, such as inflammatory disorders and hyper-progressive disease. To diminish the risk of developing serious toxicities, intratumor delivery of monoclonal antibodies could be a solution. Encouraging results have been shown in both preclinical and clinical studies. Thus, intratumor immunotherapy as a new strategy may retain efficacy while increasing safety. This approach is still an exploratory frontier in cancer research and opens up new possibilities for next-generation personalized medicine. Local intratumor delivery can be achieved through many means, but an attractive approach is the use of gene therapy vectors expressing mAbs inside the tumor mass. Here, we summarize basic, translational, and clinical results of intratumor mAb delivery, together with descriptions of non-viral and viral strategies for mAb delivery in preclinical and clinical development. Currently, this is an expanding research subject that will surely play a key role in the future of oncology., The OncoImmunology group is funded by the Spanish Association against Cancer (AECC) (grant number PROYE16001ESCO); Instituto de Salud Carlos III (ISCIII)-FEDER project grants (grant numbers FIS PI17/02119, FIS PI20/00010, COV20/00000, TRANSPOCART ICI19/00069); a Biomedicine Project grant from the Department of Health of the Government of Navarre (grant number BMED 050-2019); strategic projects from the Department of Industry, Government of Navarre (AGATA, Ref. 0011-1411-2020-000013; LINTERNA, Ref. 0011-1411-2020-000033; DESCARTHES, 0011-1411-2019-000058); European Project Horizon 2020 Improved Vaccination for Older Adults (ISOLDA; ID: 848166). Crescendo Biologics Ltd. supported the OncoImmunology group for the development and testing of PD-1 and LAG-3 bispecific antibodies.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets

  • Chocarro de Erauso, Luisa
  • Blanco, Ester
  • Fernández-Rubio, Leticia
  • Garnica, Maider
  • Zuazo Ibarra, Miren
  • García Granda, María Jesús
  • Bocanegra Gondán, Ana Isabel
  • Echaide Górriz, Míriam
  • Johnston, Colette
  • Edwards, Carolyn J.
  • Legg, James
  • Pierce, Andrew J.
  • Arasanz Esteban, Hugo
  • Fernández Hinojal, Gonzalo
  • Vera García, Ruth
  • Ausín, Karina
  • Santamaría Martínez, Enrique
  • Fernández Irigoyen, Joaquín
  • Kochan, Grazyna
  • Escors Murugarren, David
Many cancer patients do not benefit from PD-L1/PD-1 blockade immunotherapies. PD-1 and LAG-3 co-upregulation in T-cells is one of the major mechanisms of resistance by establishing a highly dysfunctional state in T-cells. To identify shared features associated to PD-1/LAG-3 dysfunctionality in human cancers and T-cells, multiomic expression profiles were obtained for all TCGA cancers immune infiltrates. A PD-1/LAG-3 dysfunctional signature was found which regulated immune, metabolic, genetic, and epigenetic pathways, but especially a reinforced negative regulation of the TCR signalosome. These results were validated in T-cell lines with constitutively active PD-1, LAG-3 pathways and their combination. A differential analysis of the proteome of PD-1/LAG-3 T-cells showed a specific enrichment in ubiquitin ligases participating in E3 ubiquitination pathways. PD-1/LAG-3 co-blockade inhibited CBL-B expression, while the use of a bispecific drug in clinical development also repressed C-CBL expression, which reverted T-cell dysfunctionality in lung cancer patients resistant to PD-L1/PD-1 blockade. The combination of CBL-B-specific small molecule inhibitors with anti-PD-1/anti-LAG-3 immunotherapies demonstrated notable therapeutic efficacy in models of lung cancer refractory to immunotherapies, overcoming PD-1/LAG-3 mediated resistance. © The Author(s) 2024., This research was supported by: The Spanish Association against Cancer (AECC), PROYE16001ESCO; Instituto de Salud Carlos III (ISCIII)-FEDER Project grants FIS PI20/00010, FIS PI23/00196, COV20/00237, and TRANSPOCART ICI19/00069; Biomedicine Project Grant from the Department of Health of the Government of Navarre-FEDER funds (BMED 050-2019, 51-2021, 036-2023); Strategic projects from the Department of Industry, Government of Navarre (AGATA, Ref. 0011-1411-2020-000013; LINTERNA, Ref. 0011-1411-2020-000033; DESCARTHES, 0011-1411-2019-000058); European Union Horizon 2020 ISOLDA project, under grant agreement ID: 848166. LC is financed byInstituto de Salud Carlos III (ISCIII), co-financed by FEDER funds, "ContratosPFIS: contratos predoctorales de formación en investigación en salud" (FI21/00080); ME is financed by the Navarrabiomed-Fundación Miguel Servetpredoctoral contract.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Cutting-edge CAR engineering: beyond T cells

  • Chocarro de Erauso, Luisa
  • Blanco, Ester
  • Fernández Rubio, Leticia
  • Arasanz Esteban, Hugo
  • Bocanegra Gondán, Ana Isabel
  • Echaide Górriz, Míriam
  • Garnica, Maider
  • Ramos, Pablo
  • Piñeiro Hermida, Sergio
  • Vera García, Ruth
  • Kochan, Grazyna
  • Escors Murugarren, David
Chimeric antigen receptor (CAR)-T adoptive cell therapy is one of the most promising advanced therapies for the treatment of cancer, with unprecedented outcomes in haematological malignancies. However, it still lacks efficacy in solid tumours, possibly because engineered T cells become inactive within the immunosuppressive tumour microenvironment (TME). In the TME, cells of the myeloid lineage (M) are among the immunosuppressive cell types with the highest tumour infiltration rate. These cells interact with other immune cells, mediating immunosuppression and promoting angiogenesis. Recently, the development of CAR-M cell therapies has been put forward as a new candidate immunotherapy with good efficacy potential. This alternative CAR strategy may increase the efficacy, survival, persistence, and safety of CAR treatments in solid tumours. This remains a critical frontier in cancer research and opens up a new possibility for next-generation personalised medicine to overcome TME resistance. However, the exact mechanisms of action of CAR-M and their effect on the TME remain poorly understood. Here, we summarise the basic, translational, and clinical results of CAR-innate immune cells and CAR-M cell immunotherapies, from their engineering and mechanistic studies to preclinical and clinical development., The OncoImmunology group is funded by the Spanish Association against Cancer (AECC) [grant number PROYE16001ESCO]; Instituto de Salud Carlos III (ISCIII)-FEDER project grants [grant numbers FIS PI17/02119, FIS PI20/00010, COV20/00000, TRANSPOCART ICI19/00069]; a Biomedicine Project grant from the Department of Health of the Government of Navarre [grant number BMED 050-2019]; strategic projects from the Department of Industry, Government of Navarre (AGATA, Ref. 0011-1411-2020-000013; LINTERNA, Ref. 0011-1411-2020-000033; DESCARTHES, 0011-1411-2019-000058); European Project Horizon 2020 Improved Vaccination for Older Adults (ISOLDA; ID: 848166); Crescendo Biologics Ltd. supported the OncoImmunology group for the development and testing of PD-1 and LAG-3 bispecifics.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Mrna vaccines against sars-cov-2: advantages and caveats

  • Echaide Górriz, Míriam
  • Chocarro de Erauso, Luisa
  • Bocanegra Gondán, Ana Isabel
  • Blanco, Ester
  • Kochan, Grazyna
  • Escors Murugarren, David
The application of BNT162b2 and mRNA-1273 vaccines against SARS-CoV-2 infection has constituted a determinant resource to control the COVID-19 pandemic. Since the beginning of 2021, millions of doses have been administered in several countries of North and South America and Europe. Many studies have confirmed the efficacy of these vaccines in a wide range of ages and in vulnerable groups of people against COVID-19. Nevertheless, the emergence and selection of new variants have led to a progressive decay in vaccine efficacy. Pfizer–BioNTech and Moderna developed updated bivalent vaccines—Comirnaty and Spikevax—to improve responses against the SARS-CoV-2 Omicron variants. Frequent booster doses with monovalent or bivalent mRNA vaccines, the emergence of some rare but serious adverse events and the activation of T-helper 17 responses suggest the need for improved mRNA vaccine formulations or the use of other types of vaccines. In this review, we discuss the advantages and limitations of mRNA vaccines targeting SARS-CoV-2 focusing on the most recent, related publications., The OncoImmunology group is funded by the Spanish Association against Cancer (AECC, PROYE16001ESCO); Instituto de Salud Carlos III (ISCIII)-FEDER project grants (FIS PI17/02119, FIS PI20/00010, COV20/00000, and TRANSPOCART ICI19/00069); a Biomedicine Project grant from the Department of Health of the Government of Navarre (BMED 050-2019); Strategic projects from the Department of Industry, Government of Navarre (AGATA, Ref 0011-1411-2020-000013; LINTERNA, Ref. 0011-1411-2020-000033; DESCARTHES, 0011-1411-2019-000058); This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 848166.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Clinical landscape of LAG-3-targeted therapy

  • Chocarro de Erauso, Luisa
  • Blanco, Ester
  • Arasanz Esteban, Hugo
  • Fernández Rubio, Leticia
  • Bocanegra Gondán, Ana Isabel
  • Echaide Górriz, Míriam
  • Garnica, Maider
  • Ramos, Pablo
  • Fernández Hinojal, Gonzalo
  • Vera García, Ruth
  • Kochan, Grazyna
  • Escors Murugarren, David
Lymphocyte-activated gene 3 (LAG-3) is a cell surface inhibitory receptor and a key regulator of immune homeostasis with multiple biological activities related to T-cell functions. LAG-3 is considered a next-generation immune checkpoint of clinical importance, right next to programmed cell death protein 1 (PD-1) and cytotoxic T-cell lymphocyte antigen-4 (CTLA-4). Indeed, it is the third inhibitory receptor to be exploited in human anticancer immunotherapies. Several LAG-3-antagonistic immunotherapies are being evaluated at various stages of preclinical and clinical development. In addition, combination therapies blocking LAG-3 together with other immune checkpoints are also being evaluated at preclinical and clinical levels. Indeed, the co-blockade of LAG-3 with PD-1 is demonstrating encouraging results. A new generation of bispecific PD-1/LAG-3-blocking agents have also shown strong capacities to specifically target PD-1+ LAG-3+ highly dysfunctional T cells and enhance their proliferation and effector activities. Here we identify and classify preclinical and clinical trials conducted involving LAG-3 as a target through an extensive bibliographic research. The current understanding of LAG-3 clinical applications is summarized, and most of the publically available data up to date regarding LAG-3-targeted therapy preclinical and clinical research and development are reviewed and discussed., The OncoImmunology group is funded by the Spanish Association against Cancer ( AECC ) [grant number PROYE16001ESCO ]; Instituto de Salud Carlos III (ISCIII)-FEDER project grants [grant numbers FIS PI17/02119, FIS PI20/00010, COV20/00000, TRANSPOCART ICI19/00069]; a Biomedicine Project grant from the Department of Health of the Government of Navarre [grant number BMED 050-2019 ]; strategic projects from the Department of Industry, Government of Navarre (AGATA, Ref. 0011-1411-2020-000013; LINTERNA, Ref. 0011-1411-2020-000033; DESCARTHES, 0011-1411-2019-000058); European Project Horizon 2020 Improved Vaccination for Older Adults (ISOLDA; ID: 848166); Crescendo Biologics Ltd. supported the OncoImmunology group for the development and testing of PD-1 and LAG-3 bispecifics.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Smoke, pheromone, and kairomone olfactory receptor neurons in males and females of the pine sawyer Monochamus galloprovincialis (Olivier) (Coleoptera:Cerambycidae)

  • Álvarez, Gonzalo
  • Ammagarahalli Munishamappa, Byrappa
  • Hall, David R.
  • Pajares, Juan A.
  • Gemeno Marín, César
The response of antennal olfactory receptor neurons (ORNs) of Monochamus galloprovincialis to several odourants was tested using single sensillum electrophysiology. Behaviourally active pheromone, and kairomone (host and sympatric bark beetle pheromone) odours were tested alongside smoke compounds released by burnt wood that are potentially attractive to the insect. The antennae bore several types of sensilla. Two plate areas in the proximal and distal ends of each antennal segment were covered with basiconic sensilla that responded to the odour stimuli. Sensilla basiconica contained one or two cells of different spike amplitude. The 32 male and 38 female ORNs tested responded with excitations or inhibitions to the different plant odours. In general the response of male and female receptors was very similar so they were pooled to perform a cluster analysis on ORN responses. Six ORNs were clearly specialised for pheromone reception. Responses to kairomone and smoke odours were less specific than those of pheromone, but a group of 9 cells was clearly excited by smoke compounds (mainly eugenol and 4-methyl 2-methoxyphenol), a group of 8 cells was very responsive to alpha-pinene, beta-pinene and cis-verbenol, and a group of 14 cells responded to a wider range of compounds. The rest of the cells (47%) were either non-responsive or slightly inhibited by smoke compounds. Dose-response curves were obtained for several compounds. Different compounds induced significantly different latencies and these appeared to be unrelated to their boiling point., We thank officials at Centro de Sanidad Forestal de Calabazanos, Junta de Castilla y León (Spain), for technical assistance and Sociedad Española de Desarrollos Químicos (SEDQ; Barcelona, Spain) for providing some of the chemicals. This study has been financed through grants RTA2011-00069-C03-03 and AGL2010-17486 by the Spanish Ministry of Science and Innovation. B.A. was supported by a Ph.D. fellowship from project AGL2010-17486 to C.G.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Conventional PCR Versus Next Generation Sequencing for Diagnosis of FLT3, IDH and NPM1 Mutations in Acute Myeloid Leukemia: Results of the PETHEMA PCR-LMA Study

  • Boluda, Blanca
  • Rodriguez-Veiga, Rebeca
  • Sargas, Claudia
  • Ayala, Rosa
  • Larráyoz, María José
  • Chillón, María Carmen
  • Soria-Saldise, Elena
  • Bilbao, Cristina
  • Prados de la Torre, Esther
  • Navarro, Irene
  • Martínez-Cuadrón, David
  • Gil, Cristina
  • Bernal, Teresa
  • Bergua, Juan
  • Algarra, Lorenzo
  • Tormo, Mar
  • Martínez-Sánchez, Pilar
  • Carrillo-Cruz, Estrella
  • Serrano, Josefina
  • Alonso-Domínguez, Juan Manuel
  • García, Raimundo.
  • Amigo, María Luz
  • Herrera-Puente, Pilar
  • Sayas, María-José
  • Lavilla-Rubira, Esperanza
  • García-Pérez, María José
  • Morán, Julia
  • Pérez-Santaolalla, Esther
  • Alonso-Vence, Natalia
  • Oliva, Ana
  • López, Juan Antonio
  • Barrios, Manuel
  • García-Fortes, María
  • Olave, María Teresa
  • Labrador, Jorge
  • Martínez-López, Joaquín
  • Calasanz, Mª Jose
  • García-Sanz, Ramón
  • Pérez-Simón, José A.
  • Gómez-Casares, María T
  • Sánchez-García, Joaquín
  • Mendizabal, Yolanda
  • Barragán, Eva
  • Montesinos, Pau
(This article belongs to the Special Issue New Approaches in Leukemia)., The authors would like to thank all the PETHEMA institutions and clinicians, PETHEMA data managers for data collection and management, and the central laboratory staff for sample management. A complete list of the institutions and clinicians participating in the PETHEMA epidemiologic registry of acute myeloid leukemia appears in the Supplementary Materials “Appendix”., [Simple Summary] This PETHEMA PCR-LMA study aimed to evaluate whether mutations detected by NGS (VAF cut-off of ≥5%) correlate with NPM1, FLT3-ITD, FLT3-TKD, IDH1, and IDH2 mutations detected using conventional PCR (analytical sensitivity 3%) in a nationwide network of seven reference laboratories. Between 2019 and 2021, 1685 adult acute myeloid leukemia (AML) patients with at least one centralized sample (NGS or PCR) at primary diagnosis or relapse/refractory episode were included, and 1288 paired NGS/PCR samples were analyzed. Considering PCR the gold-standard, for NPM1 NGS sensitivity was 98.5% and specificity 98.9%, for FLT3-ITD 73.8% and 99.6%, for FLT3-TKD 84.5% and 99.3%, for IDH1 98.7% and 98.7%, and for IDH2 99.1% and 97.7%, respectively. Overall, median days from sample reception until report were 7 for PCR and 28 for NGS. This study shows high concordance between NPM1 and IDH results using PCR and NGS. However, sensible important discrepancies are observed for FLT3 mutations., [Abstract] Background/Objectives: This PETHEMA PCR-LMA study aimed to evaluate whether mutations detected by NGS (VAF cut-off of ≥5%) correlate with NPM1, FLT3-ITD, FLT3-TKD, IDH1, and IDH2 mutations detected using conventional PCR (analytical sensitivity 3%) in a nationwide network of seven reference laboratories. Methods: Between 2019 and 2021, 1685 adult AML patients with at least one centralized sample (NGS or PCR) at primary diagnosis or relapse/refractory episode were included. Results: During this period, 1288 paired NGS/PCR samples (1094 at diagnosis, 103 at relapse and 88 at refractoriness) were analyzed. Considering PCR the gold-standard, for NPM1 NGS sensitivity was 98.5% and specificity 98.9%, for FLT3-ITD 73.8% and 99.6%, for FLT3-TKD 84.5% and 99.3%, for IDH1 98.7% and 98.7%, and for IDH2 99.1% and 97.7%, respectively. Overall concordance rate of positive results between NGS (and PCR was 95% (262/276) for NPM1, 72% (149/206) for FLT3-ITD, 74% (49/66) for FLT3-TKD, 87% (77/89) for IDH1 and 84% (107/127) for IDH2. Overall, median days from sample reception until report were 7 for PCR and 28 for NGS. Conclusions: This study shows high concordance between NPM1 and IDH results using PCR and NGS. However, sensible important discrepancies are observed for FLT3 mutations. In our context, rapid screening for these druggable mutations should be performed by conventional PCR., This study was supported in part by Novartis and PMP22/00069, PI18/01340, PI18/01946 and PI21/01705 Instituto de Salud Carlos III grants., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CEBPA-bZIP Mutations in AML Patients Treated With Non-Intensive Therapy: A Study by the Spanish PETHEMA Registry

  • Prados de la Torre, Esther
  • Serrano, Josefina
  • Barragán, Eva
  • Ayala, Rosa
  • Calasanz, María José
  • Chillón, María Carmen
  • Soria, Elena
  • Bilbao-Sieyro, Cristina
  • Cabello, Ana
  • Lavilla-Rubira, Esperanza
  • Almela Gallego, Ágata
  • Labrador Gómez, Jorge
  • Pérez-Simón, José A.
  • Rodríguez-Veiga, Rebeca
  • Martínez-Cuadrón, David
  • Vives, Susana
  • Bergua-Burgues, Juan Miguel
  • Ibañez Alis, Francisco
  • Gil, Cristina
  • Algarra, Lorenzo
  • Castaño, Tamara
  • Tormo, Mar
  • Bernal del Castillo, Teresa
  • Martínez Sánchez, María Del Pilar
  • Casado, Marisol
  • Arce Fernández, Olga
  • Herrera-Puente, Pilar
  • Vidriales Vicente, María Belén
  • Colorado, Mercedes
  • Madrigal Toscano, María Dolores
  • González, Bernardo Javier
  • Panero Ruiz, Miriam
  • Olave Rubio, Maite
  • Sánchez-García, Joaquín
  • Montesinos, Pau
The aim of our study was to analyze the incidence, co-mutation pattern, and prognostic impact of CEBPA gene mutations in a large multicenter consecutive series of 1367 adult patients AML patients treated with non-IT modalities. A total of 83 patients (6.1%) had mutations in CEBPA gene. Among these, 34 (2.5%) harbored mutations located in bZIP domain (bZIP in-frame N = 6) and 49 (3.6%) in other regions of the gene (other CEBPAmut). Genes most frequently co-mutated in these CEBPAmut patients were TET2 (45.8%, N = 38), SRSF2 (42.2%, N = 35), and ASXL1 (40.9%, N = 34). Using the Bradley-Terry model we identified that mutations in MDS-related genes, in TP53, and in epigenetic regulators appear to occur earlier. In contrast, genes involved in activating cell signaling appeared to occur later than CEBPAmut. Overall Survival (OS) of non-IT AML patients was analyzed according to the type of CEBPAmut. Median OS was 11.6 months in CEBPA-bZIP patients compared to 9.0 and 6.9 for patients with other CEBPAmut or CEBPAwt, respectively. When selecting 1129 AML patients treated with HMA or HMA-based combinations, CEBPA-bZIP patients had a median survival time of 11.6 months (range 9.6-NR) and 2.5 years survival probability of 20.1% which were outcomes comparable to remaining ELN2024 favorable patients. We concluded that our series of non-IT AML patients within the PETHEMA registry confirm a low percentage of CEBPA mutated cases which are frequently co-mutated with MDS related genes. Those CEBPA-bZIP cases harbor a similar median OS than those belonging to favorable ELN2024 risk category., This investigation was partially supported by Instituto de Salud Carlos III, Spain, grant PMP22/00069 and PI19/00730., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Interlaboratory cross validation of acute myeloid leukemia fusion genes and mutational targets detected by PCR: Performance of PETHEMA central laboratories

  • Coucelo, Margarida
  • Sargas, Claudia
  • Ayala, Rosa
  • Larráyoz, María José
  • Chillón, María Carmen
  • Soria, Elena
  • Bilbao, Cristina
  • Prados de la Torre, Esther
  • Amorim, Maria Luis
  • Mirales, Alberto
  • Cionfrini, Antonia
  • Simões, Ana T.
  • Oliveira, Ana C.
  • Rodríguez-Veiga, Rebeca
  • Lloret-Madrid, Pilar
  • Mendizábal, Yolanda
  • Botella, Carmen
  • Bernal, Teresa
  • Bergua, Juan
  • Algarra, Lorenzo
  • Tormo, Mar
  • Sarmento-Ribeiro, Ana Bela
  • Trigo, Fernanda
  • Cortesão, Emilia
  • Martínez-Sánchez, Pilar
  • Serrano, Josefina
  • Alonso-Domínguez, Juan Manuel
  • García, Raimundo
  • Amigo, María Luz
  • Herrera-Puente, Pilar
  • Sayas, María-José
  • Abuín, Aitor
  • Martínez-López, Joaquín
  • Calasanz, María José
  • García-Sanz, Ramón
  • Gutiérrez, Norma
  • Pérez-Simón, José A.
  • Gómez-Casares, M. Teresa
  • Sánchez-García, Joaquín
  • Montesinos, Pau
  • Barragán, Eva
  • PETHEMA Group
The rapid and accurate laboratory identification of targetable therapeutic genes, together with the implementation of measurable residual disease (MRD) based decision is essential for optimal clinical management in acute myeloid leukemia (AML). The PETHEMA (Programa Español de Tratamientos en Hematología) cooperative group comprises nine laboratories that perform centralized molecular studies by conventional PCR and Real-time quantitative PCR (RT-qPCR) for AML patients. With the aim to validate laboratories performances, we conducted three rounds of interlaboratory cross validation (ICV) for the quantification of CBFB::MYH11, RUNX1::RUNX1T1 and NPM1 and one round to determine the mutational status of NPM1, FLT3 (ITD and TKD2) IDH1 and IDH2. For RT-qPCR a total of 19 samples were tested and only 3 (15.8 %) failed to achieve 100 % concordance, corresponding to samples with low target gene mean ratios (ICV1-S4, ICV2-S1, ICV2-S6). For mutation detection in a total of 227 returned results, concordance rate ranged from 95 % to 100 %. FLT3-ITD and NPM1 mutation detection had 100 % concordant results. One false negative was reported for IDH2- R140 mutation and 4 false positives were detected: 2 FLT3-TKD2 and 2 IDH1-R132, likely reflecting differences in assay sensitivity. Overall, the results were highly satisfactory, particularly regarding MRD assessment, and highlighted key points for improvement, especially in baseline detection of FLT3-TKD2 and IDH1 mutations. This study represents the first collaborative initiative to evaluate performance of AML molecular targets within a laboratory network and underscores the importance of regular exercises to monitor performance, identify and resolve technical or interpretive discrepancies to ultimately ensure accurate clinical decision-making., This study was partially funded by the Instituto de Salud Carlos III, Spain: PMP22/00069, Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Núcleo de microbiota en el cáncer de pulmón central con enriquecimiento estreptocócico como posible marcador de diagnóstico

  • Bello, S.
  • Vengoechea, J.J.
  • Ponce-Alonso, M.
  • Figueredo, A.L.
  • Mincholé, E.
  • Rezusta, A.
  • Gambó, P.
  • Pastor, J.M.
  • Javier, Galeano
  • del Campo, R.
Background: Dysbiosis in lung cancer has been underexplored. The aim of this study was to define the bacterial and fungal microbiota of the bronchi in central lung cancer and to compare it with that of the oral and intestinal compartments. Methods: Twenty-five patients with central lung cancer and sixteen controls without antimicrobial intake during the previous month were recruited. Bacterial and fungal distribution was determined by massive sequencing of bronchial biopsies and saliva and faecal samples. Complex computational analysis was performed to define the core lung microbiota. Results: Affected and contralateral bronchi of patients have almost identical microbiota dominated by Streptococcus, whereas Pseudomonas was the dominant genera in controls. Oral and pulmonary ecosystems were significantly more similar in patients, probably due to microaspirations. Streptococcal abundance in the bronchi differentiated patients from controls according to a ROC curve analysis (90.9% sensitivity, 83.3% specificity, AUC = 0.897). The saliva of patients characteristically showed a greater abundance of Streptococcus, Rothia, Gemella and Lactobacillus. The mycobiome of controls (Candida) was significantly different from that of patients (Malassezia). Cancer patients’ bronchial mycobiome was similar to their saliva, but different from their contralateral bronchi. Conclusions: The central lung cancer microbiome shows high levels of Streptococcus, and differs significantly in its composition from that of control subjects. Changes are not restricted to tumour tissue, and seem to be the consequence of microaspirations from the oral cavity. These findings could be useful in the screening and even diagnosis of this disease.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Smoke, pheromone, and kairomone olfactory receptor neurons in males and females of the pine sawyer Monochamus galloprovincialis (Olivier) (Coleoptera:Cerambycidae)

  • Álvarez, Gonzalo
  • Ammagarahalli Munishamappa, Byrappa
  • Hall, David R.
  • Pajares, Juan A.
  • Gemeno Marín, César
The response of antennal olfactory receptor neurons (ORNs) of Monochamus galloprovincialis to several odourants was tested using single sensillum electrophysiology. Behaviourally active pheromone, and kairomone (host and sympatric bark beetle pheromone) odours were tested alongside smoke compounds released by burnt wood that are potentially attractive to the insect. The antennae bore several types of sensilla. Two plate areas in the proximal and distal ends of each antennal segment were covered with basiconic sensilla that responded to the odour stimuli. Sensilla basiconica contained one or two cells of different spike amplitude. The 32 male and 38 female ORNs tested responded with excitations or inhibitions to the different plant odours. In general the response of male and female receptors was very similar so they were pooled to perform a cluster analysis on ORN responses. Six ORNs were clearly specialised for pheromone reception. Responses to kairomone and smoke odours were less specific than those of pheromone, but a group of 9 cells was clearly excited by smoke compounds (mainly eugenol and 4-methyl 2-methoxyphenol), a group of 8 cells was very responsive to alpha-pinene, beta-pinene and cis-verbenol, and a group of 14 cells responded to a wider range of compounds. The rest of the cells (47%) were either non-responsive or slightly inhibited by smoke compounds. Dose-response curves were obtained for several compounds. Different compounds induced significantly different latencies and these appeared to be unrelated to their boiling point., We thank officials at Centro de Sanidad Forestal de Calabazanos, Junta de Castilla y León (Spain), for technical assistance and Sociedad Española de Desarrollos Químicos (SEDQ; Barcelona, Spain) for providing some of the chemicals. This study has been financed through grants RTA2011-00069-C03-03 and AGL2010-17486 by the Spanish Ministry of Science and Innovation. B.A. was supported by a Ph.D. fellowship from project AGL2010-17486 to C.G.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Low doses of LPS exacerbate the inflammatory response and trigger death on TLR3-primed human monocytes

  • Monguió-Tortajada, Marta|||0000-0003-2125-0810
  • Franquesa, Marcella|||0000-0002-1287-8908
  • Sarrias, Maria-Rosa|||0000-0001-6929-8069
  • Borràs i Serres, Francesc Enric|||0000-0003-4038-1912
TLR sensing of pathogens triggers monocyte activation to initiate the host innate immune response to infection. Monocytes can dynamically adapt to different TLR agonists inducing different patterns of inflammatory response, and the sequence of exposure to TLRs can dramatically modulate cell activation. Understanding the interactions between TLR signalling that lead to synergy, priming and tolerance to TLR agonists may help explain how prior infections and inflammatory conditioning can regulate the innate immune response to subsequent infections. Our goal was to investigate the role of MyD88-independent/dependent TLR priming on modulating the monocyte response to LPS exposure. We stimulated human blood monocytes with agonists for TLR4 (LPS), TLR3 (poly(I:C)) and TLR7/8 (R848) and subsequently challenged them to low doses of endotoxin. The different TLR agonists promoted distinct inflammatory signatures in monocytes. Upon subsequent LPS challenge, LPS- and R848-primed monocytes did not enhance the previous response, whereas poly(I:C)-primed monocytes exhibited a significant inflammatory response concomitant with a sharp reduction on cell viability. Our results show that TLR3-primed monocytes are prompted to cell death by apoptosis in the presence of low endotoxin levels, concurrent with the production of high levels of TNFα and IL6. Of note, blocking of TNFR I/II in those monocytes did reduce TNFα production but did not abrogate cell death. Instead, direct signalling through TLR4 was responsible of such effect. Collectively, our study provides new insights on the effects of cross-priming and synergism between TLR3 and TLR4, identifying the selective induction of apoptosis as a strategy for TLR-mediated host innate response.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Risk Model for Prostate Cancer Using Environmental and Genetic Factors in the Spanish Multi-Case- Control (MCC) Study

  • Gomez-Acebo, Ines|||0000-0001-8793-8314
  • Dierssen-Sotos, Trinidad|||0000-0002-6127-0077
  • Fernández-Navarro, Pablo|||0000-0001-9427-2581
  • Palazuelos, Camilo
  • Morros, Rosa|||0000-0001-6752-8748
  • Aragonés, Nuria
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • Jiménez Monleón, Jose J.
  • Ruiz Cerdá, José Luis
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Ruiz-Dominguez, José Manuel
  • Alonso Molero, Jessica|||0000-0002-1939-8798
  • Pollán, Marina|||0000-0002-4328-1565
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Llorca, Javier|||0000-0001-8569-861X
Prostate cancer (PCa) is the second most common cancer among men worldwide. Its etiology remains largely unknown compared to other common cancers. We have developed a risk stratification model combining environmental factors with family history and genetic susceptibility. 818 PCa cases and 1,006 healthy controls were compared. Subjects were interviewed on major lifestyle factors and family history. Fifty-six PCa susceptibility SNPs were genotyped. Risk models based on logistic regression were developed to combine environmental factors, family history and a genetic risk score. In the whole model, compared with subjects with low risk (reference category, decile 1), those carrying an intermediate risk (decile 5) had a 265% increase in PCa risk (OR = 3.65, 95% CI 2.26 to 5.91). The genetic risk score had an area under the ROC curve (AUROC) of 0.66 (95% CI 0.63 to 0.68). When adding the environmental score and family history to the genetic risk score, the AUROC increased by 0.05, reaching 0.71 (95% CI 0.69 to 0.74). Genetic susceptibility has a stronger risk value of the prediction that modifiable risk factors. While the added value of each SNP is small, the combination of 56 SNPs adds to the predictive ability of the risk model.
Dipòsit Digital de Documents de la UAB
Publicación Estudio, informe, memoria (Report)

Seguiment d'indicadors socioecològics a la conca de la Tordera, memòria 2012

  • Boada, Martí|||0000-0002-3159-2286
  • Sánchez Mateo, Sònia|||0000-0001-6544-2967
  • Miralles, Marta
  • Maneja, Roser|||0000-0001-8690-1114
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Alkylphenolic compounds and risk of breast and prostate cancer in the MCC-Spain study

  • Peremiquel-Trillas, Paula
  • Benavente, Yolanda|||0000-0003-1422-4614
  • Martín-Bustamante, Mayte
  • Casabonne, Delphine
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Gomez-Acebo, Ines|||0000-0001-8793-8314
  • Oliete-Canela, Anna
  • Diéguez-Rodríguez, Marta
  • Tusquets, Ignasi
  • Amiano, Pilar
  • Mengual, Lourdes
  • Ardanaz, Eva
  • Capelo, Rocío
  • Molina de la Torre, Antonio José
  • Salas Trejo, Dolores
  • Fernández-Tardon, Guillermo|||0000-0002-7680-158X
  • Lope, Virginia
  • Jimenez-Moleon, José J.
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • Dierssen-Sotos, Trinidad|||0000-0002-6127-0077
  • Azpiri, Mikel
  • Muñoz, Montse
  • Guevara, Marcela|||0000-0001-9242-6364
  • Fernández-Villa, Tania|||0000-0002-9049-3026
  • Molina-Barceló, Ana|||0000-0001-5113-6475
  • Aragonés, Nuria
  • Pollán, Marina|||0000-0002-4328-1565
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • Alguacil, Juan|||0000-0003-2703-9725
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • De Sanjose, Silvia|||0000-0002-5909-676X
  • Costas, Laura
Background: Alkylphenolic compounds are chemicals with endocrine disrupting properties that have been widely used in industry with important changes in their usage over time. Few epidemiologic studies have evaluated the effect of alkylphenolic compounds on human health. Objectives: We investigated whether occupational exposure to alkylphenolic compounds is associated with breast and prostate cancer. Methods: We carried out a population-based case-control study including 1513 incident cases of breast cancer, 1095 of prostate cancer, and 3055 controls, frequency matched by sex, age and region. Occupational exposure to alkylphenolic compounds was estimated using a recently developed job-exposure matrix, which considered different scenarios of exposure and different subtypes of alkylphenolic compounds. Results: History of occupational exposure to alkylphenolic compounds was modestly associated with breast cancer (OR = 1.23; 95% CI = 1.01-1.48). Within the different scenarios, the occupational use of domestic tensioactives was positively associated with breast cancer (OR = 1.28; 95% CI = 1.02-1.60), while occupational exposure in other scenarios showed mostly a suggestion of a similar positive associations. Exposure to nonylphenol ethoxylates was positively associated with breast cancer (OR = 1.21; 95% CI = 1.00-1.47), while exposure to other compounds was uncommon. In general, we did not observe associations between alkylphenolic compounds and prostate cancer, except for a positive association among men occupationally exposed to cosmetic, hair and personal hygiene products. Conclusions: Our findings suggest a modest association between breast cancer risk and occupational exposure to alkylphenolic compounds, and no associations between these compounds and prostate cancer risk. These findings warrant further corroboration in other studies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Tumour characteristics and survivorship in a cohort of breast cancer, the MCC-Spain study

  • Gomez-Acebo, Ines|||0000-0001-8793-8314
  • Dierssen-Sotos, Trinidad|||0000-0002-6127-0077
  • Palazuelos-Calderón, Camilo
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Amiano, Pilar
  • Guevara, Marcela|||0000-0001-9242-6364
  • Molina de la Torre, Antonio José
  • Domingo, Laia|||0000-0003-4420-0891
  • Fernández-Ortiz, María|||0000-0003-0017-875X
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • Alguacil, Juan|||0000-0003-2703-9725
  • Fernández-Tardon, Guillermo|||0000-0002-7680-158X
  • Ibáñez, Josefa
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • Diaz-Santos, Marian
  • Alonso, M. Henar
  • Alonso Molero, Jessica|||0000-0002-1939-8798
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • García Palomo, Andrés|||0000-0002-9159-9025
  • Ardanaz, Eva
  • Molinuevo, Amaia
  • Aragonés, Nuria
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Pollán, Marina|||0000-0002-4328-1565
  • Llorca, Javier|||0000-0001-8569-861X
The objective of this study is to analyse the relative survival with breast cancer in women diagnosed after new treatments were generalised and to ascertain the current effect that tumour characteristics such as grade, stage or subtype have on survival as well as the new AJCC-pathological prognostic score. The breast cancer MCC-Spain follow-up study is a prospective cohort study of 1685 incident breast cancer cases. Women between 20 and 85 years old were recruited between the years 2008 and 2013 in 18 hospitals located in 10 Spanish provinces and they have been followed until 2017/2018. Relative survival was estimated after 3, 5 and 8 years of follow-up using Ederer II method. In addition, Weibull regression adjusted by age, hospital, grade and stage was used to investigate prognosis factors. Among components of TNM staging system, tumour size greater than 50 mm (i.e. T3 or T4) more than doubled the risk of dying, while N3 nodal involvement and presence of metastasis had a huge effect on mortality. The AJCC pathological prognostic score strongly correlated with survival; thus, hazard ratios increased as the score rose, being 2.31, 4.00, 4.94, 7.92, 2.26, 14.9 and 58.9 for scores IB, IIA, IIB, IIIA, IIIB, IIIC and IV, respectively. Both TNM staging and histological/molecular biomarkers are associated with overall survival in Spanish women with breast cancer; when both are combined in the AJCC pathological prognosis score, the prognostic value improved with risk indices that increased rapidly as the pathological prognosis score increased The online version of this article (10.1007/s10549-020-05600-x) contains supplementary material, which is available to authorised users.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Effect of mistimed eating patterns on breast and prostate cancer risk (MCC-Spain Study)

  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Espinosa, Ana|||0000-0001-7399-3267
  • Castelló, Adela|||0000-0002-1308-9927
  • Gomez-Acebo, Ines|||0000-0001-8793-8314
  • Guevara, Marcela|||0000-0001-9242-6364
  • Martín, Vicente|||0000-0003-0552-2804
  • Amiano, Pilar
  • Alguacil, Juan|||0000-0003-2703-9725
  • Peiro, Rosana
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • Costas, Laura
  • Fernández-Tardon, Guillermo|||0000-0002-7680-158X
  • Jimenez, Jose Juan
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Llorca, Javier|||0000-0001-8569-861X
  • Moreno-Iribas, Conchi|||0000-0001-6537-0131
  • Fernández-Villa, Tania|||0000-0002-9049-3026
  • Oribe, Madalen
  • Aragonés, Nuria
  • Papantoniou, Kyriaki|||0000-0002-0340-9659
  • Pollán, Marina|||0000-0002-4328-1565
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • Romaguera, Dora|||0000-0002-5762-8558
Modern life involves mistimed sleeping and eating patterns that in experimental studies are associated with adverse health effects. We assessed whether timing of meals is associated with breast and prostate cancer risk taking into account lifestyle and chronotype, a characteristic correlating with preference for morning or evening activity. We conducted a population-based case-control study in Spain, 2008-2013. In this analysis we included 621 cases of prostate and 1,205 of breast cancer and 872 male and 1,321 female population controls who had never worked night shift. Subjects were interviewed on timing of meals, sleep and chronotype and completed a Food Frequency Questionaire. Adherence to the World Cancer Research Fund/American Institute of Cancer Research recommendations for cancer prevention was examined. Compared with subjects sleeping immediately after supper, those sleeping two or more hours after supper had a 20% reduction in cancer risk for breast and prostate cancer combined (adjusted Odds Ratio [OR] = 0.80, 95%CI 0.67-0.96) and in each cancer individually (prostate cancer OR = 0.74, 0.55-0.99; breast cancer OR = 0.84, 0.67-1.06). A similar protection was observed in subjects having supper before 9 pm compared with supper after 10 pm. The effect of longer supper-sleep interval was more pronounced among subjects adhering to cancer prevention recommendations (OR both cancers= 0.65, 0.44-0.97) and in morning types (OR both cancers = 0.66, 0.49-0.90). Adherence to diurnal eating patterns and specifically a long interval between last meal and sleep are associated with a lower cancer risk, stressing the importance of evaluating timing in studies on diet and cancer. What's new? Evidence shows that long-term disruption of endogenous circadian rhythms may be associated with cancer. The effects of mistimed sleeping and eating patterns that come with modern life are however less clear. This large Spanish population-based study examined whether meal timing and sleep patterns are associated with the two most common nightshift-related cancers. Adherence to a more diurnal eating pattern, and specifically an early supper and a long interval between last meal and sleep were associated with a lower breast and prostate cancer risk, stressing the importance of evaluating circadian rhythms in diet and cancer studies and revisiting recommendations for prevention.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Changes in Local Atrial Electrograms and Surface ECG Induced by Acute Atrial Myocardial Infarction

  • Amorós Figueras, Gerard|||0000-0002-2109-5550
  • Roselló-Díez, Elena|||0000-0003-2258-3246
  • Sanchez-Quintana, Damian
  • Casabella Ramón, Sergi|||0000-0001-7597-350X
  • Jorge, Esther|||0000-0002-2777-0000
  • Nevado-Medina, Jorge
  • Arzamendi, Dabit|||0000-0001-7543-5867
  • Millán, Xavier|||0000-0001-6519-4190
  • Alonso-Martin, Concepción|||0000-0001-8041-0445
  • Guerra Ramos, José María|||0000-0001-5397-9177
  • Cinca, Juan|||0000-0003-4819-4265
Atrial coronary branch occlusion is a hardly recognizable clinical entity that can promote atrial fibrillation. The low diagnostic accuracy of the ECG could deal with the characteristics of the ischemia-induced changes in local atrial electrograms, but these have not been described. We analyzed the effects of selective acute atrial branch occlusion on local myocardial structure, atrial electrograms, and surface ECG in an experimental model close to human cardiac anatomy and electrophysiology. Six anesthetized open-chest anesthetized pigs underwent surgical occlusion of an atrial coronary branch arising from the right coronary artery during 4 h. Atrial electrograms and ECG were simultaneously recorded. One additional pig acted as sham control. In all cases, the hearts were processed for anatomopathological analysis. Atrial branch occlusion induced patchy atrial necrosis with sharp border zone. During the first 30 min of occlusion, atrial electrograms showed progressive R wave enlargement (1.8 ± 0.6 mV vs. 2.5 ± 1.1 mV, p < 0.01), delayed local activation times (28.5 ± 8.9 ms vs. 36.1 ± 16.4 ms, p < 0.01), ST segment elevation (-0.3 ± 0.3 mV vs. 1.0 ± 1.0 mV, p < 0.01), and presence of monophasic potentials. Atrial ST segment elevation decreased after 2 h of occlusion. The electrical border zone was ∼1 mm and expanded over time. After 2 h of occlusion, the ECG showed a decrease in P wave amplitude (from 0.09 ± 0.04 mV to 0.05 ± 0.04 mV after 165 min occlusion, p < 0.05) and duration (64.4 ± 8.0 ms vs. 80.9 ± 12.6 ms, p < 0.01). Selective atrial branch occlusion induces patchy atrial infarction and characteristic changes in atrial activation, R/S wave, and ST segment that are not discernible at the ECG. Only indirect changes in P wave amplitude and duration were appreciated in advanced stages of acute coronary occlusion.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Dietary Constituents, Relationship with Breast Cancer Prognostic (MCC-SPAIN Follow-Up)

  • Dierssen-Sotos, Trinidad|||0000-0002-6127-0077
  • Gomez-Acebo, Ines|||0000-0001-8793-8314
  • Gutiérrez-Ruiz, Nuria
  • Aragonés, Nuria
  • Amiano, Pilar
  • Molina de la Torre, Antonio José
  • Guevara, Marcela|||0000-0001-9242-6364
  • Alonso Molero, Jessica|||0000-0002-1939-8798
  • Obón-Santacana, Mireia|||0000-0003-4646-3513
  • Fernández-Tardon, Guillermo|||0000-0002-7680-158X
  • Molina-Barceló, Ana|||0000-0001-5113-6475
  • Alguacil, Juan|||0000-0003-2703-9725
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • Rodríguez-Cundín, Paz
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • Canseco Fernandez, Rosario
  • Castilla, Jesus|||0000-0002-6396-7265
  • Molinuevo, Amaia
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Pollán, Marina|||0000-0002-4328-1565
  • Llorca, Javier|||0000-0001-8569-861X
The aim of this study was to characterize the relationship between the intake of the major nutrients and prognosis in breast cancer. A cohort based on 1350 women with invasive (stage I-IV) breast cancer (BC) was followed up. Information about their dietary habits before diagnosis was collected using a semi-quantitative Food Frequency Questionnaire. Participants without FFQ or with implausible energy intake were excluded. The total amount consumed of each nutrient (Kcal/day) was divided into tertiles, considering as "high intakes" those above third tertile. The main effect studied was overall survival. Cox regression was used to assess the association between death and nutrient intake. During a median follow-up of 6.5 years, 171 deaths were observed. None of the nutrients analysed was associated with mortality in the whole sample. However, in normal-weight women (BMI 18.5-25 kg/m 2) a high intake of carbohydrates (≥809 Kcal/day), specifically monosaccharides (≥468 Kcal/day), worsened prognostic compared to lowest (≤352 Kcal/day). Hazard Ratios (HRs) for increasing tertiles of intake were HR:2.22 95% CI (1.04 to 4.72) and HR:2.59 95% CI (1.04 to 6.48), respectively (p trend = 0.04)). Conversely, high intakes of polyunsaturated fats (≥135 Kcal/day) improved global survival (HR: 0.39 95% CI (0.15 to 1.02) p -trend = 0.05) compared to the lowest (≤92.8 kcal/day). In addition, a protective effect was found substituting 100 kcal of carbohydrates with 100 kcal of fats in normal-weight women (HR: 0.76 95% CI (0.59 to 0.98)). Likewise, in premenopausal women a high intake of fats (≥811 Kcal/day) showed a protective effect (HR:0.20 95% CI (0.04 to 0.98) p trend = 0.06). Finally, in Estrogen Receptors (ER) negative tumors, we found a protective effect of high intake of animal proteins (≥238 Kcal/day, HR: 0.24 95% CI (0.06 to 0.98). According to our results, menopausal status, BMI and ER status could play a role in the relationship between diet and BC survival and must be taken into account when studying the influence of different nutrients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Sex as a prognostic factor for mortality in critically ill adults with sepsis, A systematic review and meta-analysis

  • Antequera, Alba|||0000-0002-1670-6302
  • López Alcalde, Jesús|||0000-0002-1598-8790
  • Stallings, E.
  • Muriel, Alfonso|||0000-0002-4805-4011
  • Fernández-Félix, Borja|||0000-0002-8798-019X
  • del Campo, Rosa|||0000-0003-1147-7923
  • Ponce-Alonso, Manuel|||0000-0002-3239-9373
  • Fidalgo, P.
  • Halperin, Ana Verónica
  • Madrid-Pascual, Olaya|||0000-0002-2861-0121
  • Álvarez-Díaz, Noelia|||0000-0002-5904-3609
  • Solà Arnau, Ivan|||0000-0003-0078-3706
  • Gordo Vidal, Federico|||0000-0001-9605-1918
  • Urrútia, Gerard|||0000-0002-8850-0960
  • Zamora, Javier|||0000-0003-4901-588X
Objective To assess the role of sex as an independent prognostic factor for mortality in patients with sepsis admitted to intensive care units (ICUs). Design Systematic review and meta-analysis. Data sources MEDLINE, Embase, Web of Science, ClinicalTrials.gov and the WHO Clinical Trials Registry from inception to 17 July 2020. Study selection Studies evaluating independent associations between sex and mortality in critically ill adults with sepsis controlling for at least one of five core covariate domains prespecified following a literature search and consensus among experts. Data extraction and synthesis Two authors independently extracted and assessed the risk of bias using Quality In Prognosis Studies tool. Meta-analysis was performed by pooling adjusted estimates. The Grades of Recommendations, Assessment, Development and Evaluation approach was used to rate the certainty of evidence. Results From 14 304 records, 13 studies (80 520 participants) were included. Meta-analysis did not find sex-based differences in all-cause hospital mortality (OR 1.02, 95% CI 0.79 to 1.32; very low-certainty evidence) and all-cause ICU mortality (OR 1.19, 95% CI 0.79 to 1.78; very low-certainty evidence). However, females presented higher 28-day all-cause mortality (OR 1.18, 95% CI 1.05 to 1.32; very low-certainty evidence) and lower 1-year all-cause mortality (OR 0.83, 95% CI 0.68 to 0.98; low-certainty evidence). There was a moderate risk of bias in the domain adjustment for other prognostic factors in six studies, and the certainty of evidence was further affected by inconsistency and imprecision. Conclusion The prognostic independent effect of sex on all-cause hospital mortality, 28-day all-cause mortality and all-cause ICU mortality for critically ill adults with sepsis was uncertain. Female sex may be associated with decreased 1-year all-cause mortality. PROSPERO registration number CRD42019145054.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Symmetrization inequalities and Sobolev emmbedings

  • Martín, Joaquim|||0000-0002-7467-787X
  • Milman, Mario|||0000-0003-3735-8009
We prove new extended forms of the Pólya-Szegö symmetrization principle. As a consequence new sharp embedding theorems for generalized Besov spaces are proved, including a sharpening of the limiting cases of the classical Sobolev embedding theorem. In particular, a surprising self-improving property of certain Sobolev embeddings is uncovered.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Characterization of rearrangement invariant spaces eith fixed points for the Hardy-Littlewood maximal operator

  • Martín, Joaquim|||0000-0002-7467-787X
  • Soria, Javier
We characterize the rearrangement invariant spaces for which there exists a nonconstant fixed point, for the Hardy-Littlewood maximal operator (the case for the spaces Lp (Rn) was first considered in [7]). The main result that we prove is that the space Ln/(n-2),∞(Rn) ∩ L∞(Rn) is minimal among those having this property.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Weighted norm inequalites and indices

  • Martín, Joaquim|||0000-0002-7467-787X
  • Milman, Mario|||0000-0003-3735-8009
We extend and simplify several classical results on weighted norm inequalities for classical operators acting on rearrangement invariant spaces using the theory of indices. As an application we obtain necessary and sufficient conditions for generalized Hardy type operators to be bounded on Λp(w), Λp,∞ (w), Γp(w) and Γp,∞(w).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Entropy function spaces and interpolation

  • Cerdà Martín, Joan Lluís
  • Coll, Heribert
  • Martín, Joaquim|||0000-0002-7467-787X
We associate to every function space, and to every entropy function E, a scale of spaces Λp,q (E) similar to the classical Lorentz spaces Lp,q. Necessary and sufficient conditions for they to be normed spaces are proved, their role in real interpolation theory is analyzed, and a number of applications to functional and interpolation properties of several variants of Lorentz spaces and entropy spaces are given.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Equivalent expressions for norms in classical Lorentz spaces

  • Boza, Santiago
  • Martín, Joaquim|||0000-0002-7467-787X
We characterize the weights w such that ∫0∞ f*(s)pw(s) ds ≃ ∫0∞ (f**(s) - f*(s))pw(s) ds. Our result generalizes a result due to Bennett-De Vore-Sharpley, where the usual Lorentz Lp,q norm is replaced by an equivalent expression involving the functional f** - f*. Sufficient conditions for the boundedness of maximal Calderón-Zygmund singular integral operators between classical Lorentz spaces are also given.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Commutators for fourier multipliers on Besov spaces

  • Cerdà Martín, Joan Lluís
  • Martín, Joaquim|||0000-0002-7467-787X
If T is any bounded linear operator on Besov spaces Bpσj,qj(Rn)(j=0,1, and 0<σ1<σ<σ0), it is proved that the commutator [T,Tμ]=TTμ -TμT is bounded on Bpσ,q (Rn), if Tμ is a Fourier multiplier such that μ is any (possibly unbounded) symbol with uniformly bounded variation on dyadic coronas.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

On interpolation of function spaces by methods defined by means of polygons

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Equality of some classical Lorentz spaces

  • Boza, Santiago
  • Martín, Joaquim|||0000-0002-7467-787X
We prove that although the class of M p -weights of Muckenhoupt is strictly smaller than class of B p -weights of Ariño and Muckenhoupt, both classes produce the same classical Lorentz spaces. An analogous result is obtained for other classes of weights.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Integrability properties of maximal convolution operators

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Functional properties of rearrangement invariant spaces defined in terms of oscillations

  • Carro, María J.|||0000-0003-3542-7971
  • Gogatishvili, Amiran|||0000-0003-3459-0355
  • Martín, Joaquim|||0000-0002-7467-787X
  • Pick, Luboš|||0000-0002-3584-1454
Function spaces whose definition involves the quantity f** - f*, which measures the oscillation of f*, have recently attracted plenty of interest and proved to have many applications in various, quite diverse fields. Primary role is played by the spaces S p (w), with 0 < p < ∞ and w a weight function on (0, ∞), defined as the set of Lebesgue-measurable functions on R such that f* (∞) = 0 and ∥f∥ S p (w):= (∫ 0∞ (f**(s) - f*(s)) p w(s)ds) 1/p < ∞. Some of the main open questions concerning these spaces relate to their functional properties, such as their lattice property, normability and linearity. We study these properties in this paper.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A saturated map of common genetic variants associated with human height

  • Yengo, Loic|||0000-0002-4272-9305
  • Vedantam, Sailaja|||0000-0003-3892-7461
  • Marouli, Eirini|||0000-0001-6179-1609
  • Sidorenko, Julia
  • Bartell, Eric
  • Sakaue, Saori|||0000-0003-3618-9717
  • Graff, Marielisa
  • Eliasen, Anders U.
  • Jiang, Yunxuan
  • Raghavan, Sridharan
  • Miao, Jenkai
  • Arias, Joshua D.
  • Graham, Sarah E.|||0000-0003-1271-2489
  • Mukamel, Ronen E.
  • Spracklen, Cassandra N.|||0000-0003-3590-7182
  • Yin, Xianyong|||0000-0001-6454-2384
  • Chen, Shyh-Huei
  • Ferreira, Teresa
  • Highland, Heather H.
  • Ji, Yingjie
  • Karaderi, Tugce|||0000-0001-9763-8139
  • Lin, Kuang
  • Lüll, Kreete
  • Malden, Deborah|||0000-0003-0567-8294
  • Medina-Gomez, Carolina|||0000-0001-7999-5538
  • Machado, Moara
  • Moore, Amy
  • Rüeger, Sina
  • Sim, Xueling|||0000-0002-1233-7642
  • Vrieze, Scott
  • Ahluwalia, Tarunveer Singh|||0000-0002-7464-3354
  • Akiyama, Masato|||0000-0002-1879-5476
  • Allison, Matthew A.
  • Álvarez, Marcus
  • Andersen, Mette korre|||0000-0001-8227-1469
  • Ani, Alireza|||0000-0002-7868-3118
  • Appadurai, Vivek
  • Arbeeva, Liubov|||0000-0001-5004-419X
  • Bhaskar, Seema
  • Bielak, Lawrence F.|||0000-0002-3443-8030
  • Bollepalli, Sailalitha|||0000-0002-8773-7149
  • Bonnycastle, Lori L.
  • Bork-Jensen, Jette
  • Bradfield, Jonathan Paul|||0000-0001-8758-2071
  • Bradford, Yuki
  • Braund, Peter S.|||0000-0001-8540-5709
  • Brody, Jennifer A.|||0000-0001-8509-148X
  • Burgdorf, Kristoffer S.
  • Cade, Brian E.|||0000-0003-1424-0673
  • Cai, H.
  • Cai, Qiuyin
  • Campbell, Archie|||0000-0003-0198-5078
  • Cañadas-Garre, Marisa|||0000-0003-1103-5658
  • Catamo, Eulalia|||0000-0002-4701-9134
  • Chai, Jin-Fang|||0000-0003-3770-1137
  • Chai, Xiaoran
  • Chang, Liching
  • Chang, Yicheng
  • Chen, Chien Hsiun
  • Chesi, Alessandra|||0000-0002-0954-7446
  • Choi, Seunghoan
  • Chung, Renhua
  • Cocca, Massimiliano|||0000-0002-1127-7596
  • Concas, Maria Pina|||0000-0003-3598-2537
  • Couture, Christian Y.
  • Cuellar-Partida, Gabriel|||0000-0001-7648-4097
  • Danning, Rebecca D.
  • Daw, E. Warwick
  • Degenhard, Frauke
  • Delgado, Graciela E.|||0000-0002-1272-7210
  • Delitala, Alessandro|||0000-0003-1729-8969
  • Demirkan, Ayşe|||0000-0002-7546-0867
  • Deng, Xuan|||0000-0003-0918-817X
  • Devineni, Poornima
  • Dietl, Alexander|||0000-0002-4091-8620
  • Dimitriou, Maria E.
  • Dimitrov, Latchezar M.
  • Dorajoo, Rajkumar|||0000-0001-6608-2051
  • Ekici, Arif B.
  • Engmann, Jorgen|||0000-0001-7015-7773
  • Fairhurst-Hunter, Zammy
  • Farmaki, Aliki Eleni
  • Faul, Jessica D.|||0000-0002-6969-6478
  • Fernandez-Lopez, Juan Carlos|||0000-0003-3680-4193
  • Forer, Lukas|||0000-0003-2139-7329
  • Francescatto, Margherita
  • Freitag-Wolf, Sandra
  • Fuchsberger, Christian|||0000-0002-5918-8947
  • Galesloot, Tessel E.
  • Gao, Yan
  • Gao, Zishan|||0000-0003-1299-0286
  • Geller, Frank
  • Giannakopoulou, Olga
  • Giulianini, Franco
  • Gjesing, Anette Prior
  • Goel, Anuj|||0000-0003-2307-4021
  • Gordon, Scott D.|||0000-0001-7623-328X
  • Gorski, Mathias M.
  • Grove, Jakob|||0000-0003-2284-5744
  • Guo, Xiuqing
  • Gustafsson, S.|||0000-0001-5894-0351
  • Haessler, Jeffrey W.
  • Hansen, Thomas Folkmann
  • Havulinna, Aki Samuli
  • Haworth, S.J.
  • He, Jing
  • Heard-Costa, Nancy L.
  • Hebbar, Prashantha|||0000-0001-6560-7063
  • Hindy, George|||0000-0002-7257-9299
  • Ho, Yuk Lam Anne
  • Hofer, Edith
  • Holliday, Elizabeth|||0000-0002-4066-6224
  • Horn, Katrin
  • Hornsby, Whitney E.
  • Hottenga, Jouke Jan|||0000-0002-5668-2368
  • Huang, Hongyan
  • Huang, Jie
  • Huerta-Chagoya, Alicia|||0000-0001-6218-3904
  • Huffman, Jennifer E.|||0000-0002-9672-2491
  • Hung, Yijen
  • Huo, Shaofeng
  • Hwang, Mi-yeong
  • Iha, Hiroyuki|||0000-0003-4261-2067
  • Ikeda, Daisuke D.|||0000-0001-8403-0327
  • Isono, Masato
  • Jackson, Anne U.|||0000-0002-9672-2547
  • Jäger, Susanne
  • Jansen, Iris E.|||0000-0003-1901-8131
  • Johansson, Ingegerd
  • Jonas, Jost Bruno
  • Jonsson, Anna Elisabet
  • Jørgensen, Torben J.
  • Kalafati, IP.|||0000-0001-5572-7491
  • Kanai, Masahiro|||0000-0001-5165-4408
  • Kanoni, Stavroula|||0000-0002-1691-9615
  • Kårhus, Line Lund
  • Kasturiratne, Anuradhani
  • Katsuya, Tomohiro|||0000-0002-8892-8828
  • Kawaguchi, Takahisa
  • Kember, Rachel L.|||0000-0001-8820-2659
  • Kentistou, Katherine A.|||0000-0002-5816-664X
  • Kim, Hanna
  • Kim, Young-jin
  • Kleber, Marcus Edi
  • Knol, Maria J.|||0000-0002-3597-1531
  • Kurbasic, Azra
  • Lauzon, Marie
  • Le, Phuong
  • Lea, Rodney A.
  • Lee, Jongyoung
  • Leonard, Hampton L.|||0000-0003-2390-8110
  • Li, Shengchao Alfred
  • Li, Xiaoyin
  • Liang, Jingjing
  • Lin, Honghuang
  • Lin, Shihyi
  • Liu, Jun|||0000-0001-5288-3042
  • Liu, Xueping
  • Lo, Ken Sin
  • Long, Jirong
  • Lores-Motta, Laura
  • Luan, Jian'fan N. An
  • Lyssenko, Valeriya
  • Lyytikäinen, Leo Pekka
  • Mahajan, Anubha|||0000-0001-5585-3420
  • Mamakou, Vasiliki
  • Mangino, Massimo
  • Manichaikul, Ani W.
  • Marten, Jonathan|||0000-0001-6916-2014
  • Mattheisen, Manuel|||0000-0002-8442-493X
  • Mavarani, Laven
  • McDaid, Aaron F.
  • Meidtner, Karina
  • Melendez, Tori L.
  • Mercader, Josep M.|||0000-0001-8494-3660
  • Milaneschi, Yuri|||0000-0002-3697-6617
  • Miller, Jason E.
  • Millwood, Iona Y.
  • Mishra, Pashupati P.|||0000-0001-5177-3431
  • Mitchell, Ruth E.
  • Møllehave, Line Tang|||0000-0001-7116-9346
  • Morgan, Anna
  • Mucha, Soeren
  • Munz, Matthias|||0000-0002-4728-3357
  • Nakatochi, Masahiro|||0000-0002-1838-4837
  • Nelson, Christopher P.
  • Nethander, Maria
  • Nho, Chu Won
  • Nielsen, Aneta A.
  • Nolte, Ilja M.|||0000-0001-5047-4077
  • Nongmaithem, Suraj S.|||0000-0001-5390-0449
  • Noordam, Raymond|||0000-0001-7801-809X
  • Ntalla, Ioanna
  • Nutile, Teresa
  • Pandit, Anita
  • Christofidou, Paraskevi
  • Pärna, Katri
  • Pauper, Marc
  • Petersen, Eva R.B.
  • Petersen, Liselotte V.
  • Pitkänen, Niina
  • Polašek, Ozren
  • Poveda, Alaitz|||0000-0001-6349-3955
  • Preuss, Michael H.
  • Pyarajan, Saiju
  • Raffield, Laura M.
  • Rakugi, Hiromi
  • Ramirez, Julia
  • Rasheed, Asif
  • Raven, Dennis
  • Rayner, Nigel W.
  • Riveros, Carlos
  • Rohde, Rebecca
  • Ruggiero, Daniela|||0000-0003-3898-7827
  • Ruotsalainen, Sanni E.|||0000-0002-1631-4069
  • Ryan, Kathleen A.
  • Sabater-Lleal, Maria|||0000-0002-0128-379X
  • Saxena, Richa
  • Scholz, Markus|||0000-0002-4059-1779
  • Sendamarai, Anoop
  • Shen, Botong
  • Shi, Jingchunzi
  • Shin, J.H.
  • Sidore, Carlo|||0000-0001-7504-7477
  • Sitlani, Collen M.|||0000-0001-7656-7482
  • Slieker, Roderick C.
  • Smit, Roelof A. J.
  • Smith, Albert V.
  • Smith, Jennifer A.|||0000-0002-3575-5468
  • Smyth, Laura J.|||0000-0001-6419-4826
  • Southam, Lorraine
  • Steinthorsdottir, Valgerdur
  • Sun, Liang
  • Takeuchi, Fumihiko
  • Tallapragada, Divya Sri Priyanka
  • Taylor, Kent|||0000-0002-2756-4370
  • Tayo, Bamidele O.
  • Tcheandjieu, Catherine
  • Terzikhan, Natalie
  • Tesolin, Paola|||0000-0002-5238-6422
  • Teumer, Alexander|||0000-0002-8309-094X
  • Theusch, Elizabeth|||0000-0002-5678-759X
  • Thompson, Deborah J.
  • Thorleifsson, Gudmar|||0000-0003-4623-9087
  • Timmers, Paul R. H. J.
  • Trompet, Stella|||0000-0001-5006-0528
  • Turman, Constance
  • Vaccargiu, Simona
  • van der Laan, Sander W.|||0000-0001-6888-1404
  • van der Most, Peter J.|||0000-0001-8450-3518
  • van Klinken, Jan Bert
  • van Setten, Jessica A.
  • Verma, Shefali Setia
  • Verweij, Niek|||0000-0002-4303-7685
  • Veturi, Yogasudha C.
  • Wang, Carol A.|||0000-0002-4301-3974
  • Wang, Chaolong
  • Wang, Lihua
  • Wang, Zhe|||0000-0003-0786-9887
  • Warren, Helen R.
  • Bin Wei, Wen
  • Wickremasinghe, Ananda|||0000-0002-6174-6784
  • Wielscher, Matthias|||0000-0003-4138-1383
  • Wiggins, Kerri L.|||0000-0003-2749-1279
  • Winsvold, Bendik Slagsvold|||0000-0003-4171-8919
  • Wong, Andrew|||0000-0003-2079-4779
  • Wu, Yang|||0000-0002-0128-7280
  • Wuttke, Matthias|||0000-0003-3420-5082
  • Xia, Rui|||0000-0003-2409-1181
  • Xie, Tian
  • Yamamoto, Ken
  • Yang, Jingyun
  • Yao, Jie
  • Young, Hannah|||0000-0002-4248-9612
  • Yousri, Noha A.|||0000-0003-1918-0331
  • Yu, Lei
  • Zeng, Lingyao
  • Zhang, Weihua
  • Zhang, Xinyuan
  • Zhao, Jinghua
  • Zhao, Wei|||0000-0002-4839-6791
  • Zhou, Wei
  • Zimmermann, Martina E.|||0000-0002-6916-4404
  • Zoledziewska, Magdalena|||0000-0002-3033-6133
  • Adair, Linda S.
  • Adams, Hieab H. H.|||0000-0003-3687-2508
  • Aguilar-Salinas, Carlos Alberto
  • Al-Mulla, Fahd|||0000-0001-5409-3829
  • Arnett, Donna|||0000-0003-2219-657X
  • Asselbergs, Folkert W.|||0000-0002-1692-8669
  • Åsvold, Bjørn Olav|||0000-0003-3837-2101
  • Attia, John Richard
  • Banas, Bernhard|||0000-0003-2076-2195
  • Bandinelli, Stefania|||0000-0002-6491-0850
  • Bennett, David Alan
  • Bergler, Tobias
  • Bharadwaj, Dwaipayan
  • Biino, Ginevra|||0000-0002-9936-946X
  • Bisgaard, Hans
  • Boerwinkle, Eric|||0000-0001-8813-0544
  • Böger, Carsten A.
  • Bønnelykke, Klaus
  • Boomsma, Dorret I.|||0000-0002-7099-7972
  • Børglum, Anders D.|||0000-0001-8627-7219
  • Borja, Judith B.
  • Bouchard, Claude|||0000-0002-0048-491X
  • Bowden, Donald W.
  • Brandslund, Ivan
  • Brumpton, Ben
  • Buring, Julie E.
  • Caulfield, Mark|||0000-0001-9295-3594
  • Chambers, John C.
  • Chandak, Giriraj R.
  • Chanock, Stephen|||0000-0002-2324-3393
  • Chaturvedi, Nish
  • Chen, Yii Der Ida
  • Chen, Zhengming|||0000-0001-6423-105X
  • Cheng, Ching-Yu|||0000-0003-0655-885X
  • Christophersen, Ingrid E.
  • Ciullo, Marina|||0000-0002-9621-9984
  • Cole, John W.|||0000-0001-9263-8930
  • Collins, Francis S.|||0000-0002-1023-7410
  • Cooper, Richard S.
  • Cruz, Miguel
  • Cucca, Francesco|||0000-0002-7414-1995
  • Cupples, L. Adrienne
  • Cutler, Michael J.
  • Damrauer, Scott M.|||0000-0001-8009-1632
  • Dantoft, Thomas M.
  • de Borst, Gert J.
  • de Groot, Lisette C.P.G.M.|||0000-0003-2778-2789
  • De Jager, Philip L.|||0000-0002-8057-2505
  • de Kleijn, D.P.V.|||0000-0003-2714-2140
  • Janaka de Silva, H.
  • Dedoussis, George V.
  • den Hollander, Anneke I.
  • Du, Shufa
  • Easton, Douglas F.|||0000-0003-2444-3247
  • Elders, Petra J. M.
  • Eliassen, A. Heather Heather
  • Ellinor, Patrick T.
  • Elmståhl, Sölve
  • Erdmann, Jeanette|||0000-0002-4486-6231
  • Evans, Michele K.
  • Fatkin, Diane
  • Feenstra, Bjarke|||0000-0003-1478-649X
  • Feitosa, Mary|||0000-0002-0933-2410
  • Ferrucci, Luigi
  • Ford, Ian
  • Fornage, Myriam|||0000-0003-0677-8158
  • Franke, Andre|||0000-0003-1530-5811
  • Franks, Paul W.|||0000-0002-0520-7604
  • Freedman, Barry I.|||0000-0003-0275-5530
  • Gasparini, Paolo
  • Gieger, Christian|||0000-0001-6986-9554
  • Girotto, Giorgia|||0000-0003-4507-6589
  • Goddard, Michael E.
  • Golightly, Yvonne M.
  • Gonzalez-Villalpando, Clicerio
  • Gordon-Larsen, P.
  • Grallert, H.
  • Grant, Struan F. A.|||0000-0003-2025-5302
  • Grarup, Niels|||0000-0001-5526-1070
  • Griffiths, L.
  • Gudnason, V.
  • Haiman, C.
  • Hakonarson, Hakon|||0000-0003-2814-7461
  • Hansen, Torben|||0000-0001-8748-3831
  • Hartman, C.A.
  • Hattersley, A.T.
  • Hayward, Caroline|||0000-0002-9405-9550
  • Heckbert, S.R.
  • Heng, C.K.
  • Hengstenberg, C.
  • Hewitt, Alex W.|||0000-0002-5123-5999
  • Hishigaki, H.
  • Hoyng, C.B.
  • Huang, Paul L.
  • Huang, W.
  • Hunt, S.C.
  • Hveem, K.
  • Hyppönen, E.
  • Iacono, William
  • Ichihara, S.
  • Ikram, M.A.
  • Isasi, C.R.
  • Jackson, R.D.
  • Jarvelin, Marjo-Riitta|||0000-0002-2149-0630
  • Jin, Zi-Bing
  • Jöckel, K.H.
  • Joshi, P.K.
  • Jousilahti, P.
  • Jukema, J.W.
  • Kähönen, M.
  • Kamatani, Yoichiro|||0000-0001-8748-5597
  • Kang, K.D.
  • Kaprio, Jaakko|||0000-0002-3716-2455
  • Kardia, S.L.R.
  • Karpe, F.
  • Kato, N.
  • Kee, F.
  • Kessler, T.
  • Khera, Amit V.
  • Khor, C.C.
  • Kiemeney, Lambertus A.
  • Kim, B.J.
  • Kim, E.K.
  • Kim, H.L.
  • Kirchhof, P.
  • Kivimaki, Mika|||0000-0002-4699-5627
  • Koh, W.P.
  • Koistinen, H.A.
  • Kolovou, G.D.
  • Kooner, J.S.
  • Kooperberg, C.
  • Köttgen, A.
  • Kovacs, P.
  • Kraaijeveld, A.
  • Kraft, Peter
  • Krauss, R.M.
  • Kumari, M.
  • Kutalik, Zoltan|||0000-0001-8285-7523
  • Laakso, Markku|||0000-0002-3394-7749
  • Lange, Leslie A.
  • Langenberg, C.
  • Launer, L.J.
  • Le Marchand, L.
  • Lee, H.
  • Lee, N.R.
  • Lehtimäki, T.
  • Li, H.
  • Li, L.
  • Lieb, Wolfgang|||0000-0003-2544-4460
  • Lin, X.
  • Lind, Lars
  • Linneberg, Allan|||0000-0002-0994-0184
  • Liu, Ching-Ti
  • Liu, Jianjun|||0000-0002-3255-3019
  • Loeffler, Markus
  • London, Barry
  • Lubitz, Steven A.
  • Lye, Stephen J.
  • Mackey, David A.
  • Mägi, Reedik
  • Magnusson, Patrik K. E.|||0000-0002-7315-7899
  • Marcus, Gregory M.|||0000-0001-5197-7696
  • Vidal, Pedro M.
  • Martin, Nicholas G.|||0000-0003-4069-8020
  • März, Winfried|||0000-0001-6083-8946
  • Matsuda, Fumihiko
  • McGarrah, Robert W.
  • McGue, Matt|||0000-0002-5580-1433
  • McKnight, Amy Jayne|||0000-0002-7482-709X
  • Medland, Sarah Elizabeth|||0000-0003-1382-380X
  • Mellström, Dan|||0000-0003-2761-3723
  • Metspalu, Andres|||0000-0002-3718-796X
  • Mitchell, Braxton|||0000-0003-4920-4744
  • Mitchell, Paul
  • Mook-Kanamori, Dennis O.
  • Morris, Andrew D.
  • Mucci, Lorelei A.
  • Munroe, Patricia B.|||0000-0002-4176-2947
  • Nalls, Mike A.
  • Nazarian, Saman
  • Nelson, Amanda E.
  • Neville, Matt J.|||0000-0002-6004-5433
  • Newton-Cheh, Christopher
  • Nielsen, Christopher S.
  • Nöthen, Markus M.|||0000-0002-8770-2464
  • Ohlsson, Claes|||0000-0002-9633-2805
  • Oldehinkel, Albertine J.|||0000-0003-3925-3913
  • Orozco, Lorena|||0000-0002-5801-9180
  • Pahkala, Katja
  • Pajukanta, Päivi
  • Palmer, Colin N. A.
  • Parra, Esteban J.|||0000-0002-2057-8577
  • Pattaro, Cristian|||0000-0002-4119-0109
  • Pedersen, Oluf
  • Pennell, Craig E.|||0000-0002-0937-6165
  • Penninx, Brenda W. J. H.
  • Pérusse, Louis|||0000-0001-6440-9698
  • Peters, Annette|||0000-0001-6645-0985
  • Peyser, Patricia A.
  • Porteous, David J.|||0000-0003-1249-6106
  • Posthuma, Danielle|||0000-0001-7582-2365
  • Power, Chris
  • Pramstaller, Peter P.
  • Province, Michael A.|||0000-0001-6102-774X
  • Qi, Qibin
  • Qu, Jia
  • Rader, Daniel J.
  • Raitakari, Olli T.
  • Ralhan, Sarju
  • Rallidis, Loukianos S.
  • Rao, Dabeeru C.
  • Redline, Susan
  • Reilly, Dermot F.
  • Reiner, Alexander P.
  • Rhee, Sang Youl|||0000-0003-0119-5818
  • Ridker, Paul M.
  • Rienstra, Michiel|||0000-0002-2581-070X
  • Ripatti, Samuli|||0000-0002-0504-1202
  • Ritchie, Marylyn D.|||0000-0002-1208-1720
  • Roden, Dan M.
  • Rosendaal, Frits|||0000-0003-2558-7496
  • Rotter, Jerome I.|||0000-0001-7191-1723
  • Rudan, Igor|||0000-0001-6993-6884
  • Rutters, Femke
  • Sabanayagam, Charumathi|||0000-0002-4042-4719
  • Saleheen, Danish|||0000-0001-6193-020X
  • Salomaa, Veikko|||0000-0001-7563-5324
  • Samani, Nilesh J.
  • Sanghera, Dharambir K.
  • Sattar, Naveed|||0000-0002-1604-2593
  • Schmidt, Börge
  • Schmidt, Helena|||0000-0001-9773-9992
  • Schmidt, Reinhold
  • Schulze, Matthias B.
  • Schunkert, Heribert|||0000-0001-6428-3001
  • Scott, Laura J.|||0000-0002-4886-5084
  • Scott, Rodney J.|||0000-0001-7724-3404
  • Sever, Peter
  • Shiroma, Eric J.
  • Shoemaker, M. Benjamin
  • Shu, Xiao-Ou
  • Simonsick, Eleanor M.
  • Sims, Mario
  • Singh, Jai Rup
  • Singleton, Andrew B.|||0000-0001-5606-700X
  • Sinner, Moritz F.
  • Smith, J. Gustav
  • Snieder, Harold|||0000-0003-1949-2298
  • Spector, Tim|||0000-0002-9795-0365
  • Stampfer, Meir J.
  • Stark, Klaus J.
  • Strachan, David P.
  • 't Hart, Leen M.
  • Tabara, Yasuharu
  • Tang, Hua
  • Tardif, J.C.
  • Thanaraj, T.A.
  • Timpson, N.J.
  • Tönjes, A.
  • Tremblay, A.
  • Tuomi, T.
  • Tuomilehto, J.
  • Tusié-Luna, M.T.
  • Uitterlinden, André G.|||0000-0002-7276-3387
  • van Dam, Rob M.
  • van der Harst, Pim|||0000-0002-2713-686X
  • Van der Velde, Nathalie
  • van Duijn, Cornelia M.|||0000-0002-2374-9204
  • van Schoor, N.M.
  • Vitart, Veronique|||0000-0002-4991-3797
  • Völker, U.
  • Vollenweider, P.
  • Völzke, Henry|||0000-0001-7003-399X
  • Wacher-Rodarte, N.H.
  • Walker, M.
  • Wang, Y.X.
  • Wareham, N.J.
  • Watanabe, R.M.
  • Watkins, Hugh
  • Weir, D.R.
  • Werge, Thomas M.
  • Widen, E.
  • Wilkens, Lynne R.
  • Willemsen, Gonneke|||0000-0003-3755-0236
  • Willett, Walter C.
  • Wilson, James F.|||0000-0001-5751-9178
  • Wong, Tien-Yin
  • Woo, Jeong-Taek|||0000-0001-9201-0713
  • Wright, Alan F.
  • Wu, Jer-Yuarn
  • Xu, Huichun|||0000-0001-8118-9607
  • Yajnik, Chittaranjan S.
  • Yokota, Mitsuhiro
  • Yuan, Jian-Min|||0000-0002-4620-3108
  • Zeggini, Eleftheria|||0000-0003-4238-659X
  • Zemel, Babette S.
  • Zheng, Wei|||0000-0003-1226-070X
  • Zhu, X.|||0000-0003-0037-411X
  • Zmuda, Joseph M.
  • Zonderman, Alan B.|||0000-0002-6523-4778
  • Zwart, John-Anker|||0000-0001-5721-0154
  • Croteau-Chonka, Damien
  • Vonk, Judith M.
  • Le Marchand, Loic
  • Chasman, Daniel I.|||0000-0003-3357-0862
  • Cho, Yoon Shin
  • Heid, Iris M.
  • McCarthy, Mark I.
  • Ng, Maggie C. Y.
  • O'Donnell, Christopher J.
  • Rivadeneira, Fernando|||0000-0001-9435-9441
  • Thorsteinsdottir, Unnur
  • Sun, Yan V.|||0000-0002-2838-1824
  • Tai, E. Shyong
  • Boehnke, Michael|||0000-0002-6442-7754
  • Deloukas, Panos|||0000-0001-9251-070X
  • Justice, Anne E.
  • Lindgren, Cecilia M.
  • Loos, Ruth J. F.|||0000-0002-8532-5087
  • Mohlke, Karen L.|||0000-0001-6721-153X
  • North, Kari E.
  • Stefánsson, Kári|||0000-0003-1676-864X
  • Walters, Robin G.|||0000-0002-9179-0321
  • Winkler, Thomas W.|||0000-0003-0292-5421
  • Young, Kristin L.|||0000-0003-0070-6145
  • Loh, Po-Ru
  • Yang, Jian|||0000-0003-4800-832X
  • Esko, Tõnu
  • Assimes, Themistocles|||0000-0003-2349-0009
  • Auton, Adam
  • Abecasis, Goncalo
  • Willer, Cristen J.|||0000-0001-5645-4966
  • Locke, Adam E.|||0000-0001-6227-198X
  • Berndt, Sonja
  • Lettre, Guillaume
  • Frayling, Timothy M.
  • Okada, Yukinori|||0000-0002-0311-8472
  • Wood, Andrew R.|||0000-0003-1726-948X
  • Visscher, PM.|||0000-0002-2143-8760
  • Hirschhorn, Joel N.|||0000-0002-1650-7901
Common single-nucleotide polymorphisms (SNPs) are predicted to collectively explain 40-50% of phenotypic variation in human height, but identifying the specific variants and associated regions requires huge sample sizes. Here, using data from a genome-wide association study of 5.4 million individuals of diverse ancestries, we show that 12,111 independent SNPs that are significantly associated with height account for nearly all of the common SNP-based heritability. These SNPs are clustered within 7,209 non-overlapping genomic segments with a mean size of around 90 kb, covering about 21% of the genome. The density of independent associations varies across the genome and the regions of increased density are enriched for biologically relevant genes. In out-of-sample estimation and prediction, the 12,111 SNPs (or all SNPs in the HapMap 3 panel) account for 40% (45%) of phenotypic variance in populations of European ancestry but only around 10-20% (14-24%) in populations of other ancestries. Effect sizes, associated regions and gene prioritization are similar across ancestries, indicating that reduced prediction accuracy is likely to be explained by linkage disequilibrium and differences in allele frequency within associated regions. Finally, we show that the relevant biological pathways are detectable with smaller sample sizes than are needed to implicate causal genes and variants. Overall, this study provides a comprehensive map of specific genomic regions that contain the vast majority of common height-associated variants. Although this map is saturated for populations of European ancestry, further research is needed to achieve equivalent saturation in other ancestries.